Slide background
Mersin Üniversitesi

  Professor Bahar Tunçtan
users.ozgecmis
:
Department
:
Faculty of Pharmacy .
Business Address
:
Faculty Of Pharmacy Department Of Pharmacology Mersın Unıversıty Mersın Turkey, 33169 .
Phone
:
+90-324-3412815 .
Internal
:
2633 .
Alternative e-mail
:
Alternative e-mail
:
Created
:
2015-06-11 13:45:01 .
Last Modification
:
2019-10-14 09:41:45 .
Researcher ID :
Scopus ID :
Orcid ID :
Scholar ID :
h-index :
Publons ID :
Point :

Degree Department/Program Institute Year
BACHELOR'S DEGREE PHARMACY GAZI UNIVERSITY 1989
1992
1996
Doctorate Thesis

1. Detection of nitric oxide synthetizing ability of macrophages from healthy and Mycobacterium tuberculosis infected people by using analytical and bioassay methods, Supervisor: Dr. Nurettin ABACIOĞLU, Gazi University, Graduate School of Health Sciences, Pharmacology Department, Ankara, Turkey, 1996.

Master Thesis

1. 1. The role of respiratory epithelium on some bronchoconstrictor agents, Supervisor: Dr. Nurettin ABACIOĞLU, Gazi University, Graduate School of Health Sciences, Pharmacology Department, Ankara, Turkey, 1992.

Title Institute Year
ASSOC. PROF. DR. GAZI UNIVERSITY 2000-11-03 - 2001-09-07
ASSOC. PROF. DR. MERSIN UNIVERSITY 2001-09-09 - 2006-05-10
PROF. DR. MERSIN UNIVERSITY 2006-05-11 - Continue
Title Dutie Institution/Other Year
HEAD OF ETHICS COMMITTEE MERSIN UNIVERSITY CLINICAL RESEARCH ETHICS COMITTEE MERSIN UNIVERSITY 2011-11-28 - Continue
2016-01-11 - 2019-01-11
2016-01-11 - 2020-01-11
2015-12-25 - 2018-12-25
2015-12-25 - 2018-12-25
2015-12-25 - 2018-12-25
2012-12-25 - 2015-12-25
2012-12-25 - 2015-12-25
2012-12-25 - 2015-12-25
2012-12-25 - 2015-12-25
2012-06-18 - 2015-06-18
2012-06-18 - 2015-06-18
International - Covered by ULAKBIM 0
2018
1. Cevher, F.; ünal, S.; Küçükkavruk, .; Taşdelen, B.; Tunçtan, B. . TURKIYE KLINIKLERI TIP BILIMLERI DERGISI, 2018, 38, 30-39. 0 + 0
10.5336/medsci.2017-57070

International - SCI/SCI-Expanded category 41900
2019
71. şahan fırat, S.; Temiz reşitoğlu, M.; Güden, D.; şenol, .; Sarı, A.; çil, M.; ünsal, D.; Korkmaz, B.; Tunçtan, B.; Malık, K. NF-κB activation mediates LPS- or zymosan-induced hypotension and inflammation reversed by BAY61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2019, 46, 173-182. 100 + 0
10.1111/1440-1681.13045

2018
70. Tunçtan, B. . CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2018, 45, 155-165. 1000 + 0
10.1111/1440-1681.12864

69. şahan fırat, S.; Temiz reşitoğlu, M.; Güden, D.; Küçükkavruk, .; Tunçtan, B.; Sarı, A.; Koçak, Z.; Malık, K. . INFLAMMATION, 2018, 41, 276-298. 350 + 0
68. Tunçtan, B.; Küçükkavruk, .; Temiz reşitoğlu, M.; Güden, D.; Sarı, A.; şahan fırat, S. . INFLAMMATION, 2018, 41, 337-355. 850 + 0
10.1007/s10753-017-0691-5

2017
67. Temiz-resitoglu, M.; Kucukkavruk, S.; Guden, D.; Cecen, P.; Sari, A.; Tunctan, B.; Gorur, A.; Tamer-gumus, L.; Buharalioglu, C.; Malik, K. Activation of mTOR/IκB-α/NF-κB pathway contributes to LPS-induced hypotension and inflammation in rats. EUROPEAN JOURNAL OF PHARMACOLOGY, 2017, 802, 7-19. 150 + 0
http://dx.doi.org/10.1016/j.ejphar.2017.02.034

66. Tunctan, B.; Kucukkavruk, S.; Temiz resitoglu, M.; Güden, D.; Sari, A.; sahan firat, S.; Paudyal, M.; Falck, J.; Malik, K. Inhibition of NLRP3 Inflammasome Contributes to Protective Effect of 5,14-HEDGE against Lipopolysaccharide-Induced Septic Shock. INTERNATIONAL JOURNAL OF PHARMACOLOGY, 2017, 13, 654-666. 700 + 0
http://scialert.net/onlinefirst.php?issn=1811-7775

Publications_002.pdf

65. Dolunay, A.; Senol, S.; Temiz-resitoglu, M.; Guden, D.; Sari, A.; Sahan-firat, S.; Tunctan, B. Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms. INFLAMMATION, 2017, 40, 366-386. 200 + 0
http://dx.doi.org/10.1007/s10753-016-0483-3

2016
64. Senol, S.; Temiz, M.; Guden, D.; Cecen, P.; Sari, A.; Sahan-firat, S.; Falck, J.; Dakarapu, R.; Malik, K.; Tunctan, B. Contribution of PPARα/β/γ, AP-1, importin-α3, and RXRα to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against hypotension, tachycardia, and inflammation in a rat model of septic shock. INFLAMMATION RESEARCH , 2016, 65, 367-387. 100 + 0
http://dx.doi.org/10.1007/s00011-016-0922-5

2014
63. Battal, D.; Cok, I.; Unlusayin, I.; Tunctan, B. Development and validation of an LC-MS/MS method for simultaneous quantitative analysis of free and conjugated bisphenol A in human urine. BIOMEDICAL CHROMATOGRAPHY, 2014, 28, 686-693. 650 + 10
https://dx.doi.org/10.1002/bmc.3090


Times Cited: 2
62. Battal, D.; Cok, I.; Unlusayin, I.; Aktas, A.; Tunctan, B. Determination of urinary levels of Bisphenol A in a Turkish population. ENVIRONMENTAL MONITORING AND ASSESSMENT, 2014, 186, 8443-8452. 500 + 0
https://dx.doi.org/10.1007/s10661-014-4015-z

61. Sari, A.; Kacan, M.; Unsal, D.; Firat, S.; Buharalioglu, C.; Vezir, O.; Korkmaz, B.; Cuez, T.; Canacankatan, N.; Sucu, N. Contribution of RhoA/Rho-kinase/MEK1/ERK1/2/iNOS pathway to ischemia/reperfusion-induced oxidative/nitrosative stress and inflammation leading to distant and target organ injury in rats. EUROPEAN JOURNAL OF PHARMACOLOGY, 2014, 723, 234-245. 0 + 15
https://dx.doi.org/10.1016/j.ejphar.2013.11.027


Times Cited: 3
60. Kucuk, M.; Sucu, N.; Firat, S.; Aytacoglu, B.; Vezir, O.; Bozali, C.; Canacankatan, N.; Kul, S.; Tunctan, B. Role of ACE I/D gene polymorphisms on the effect of ramipril in inflammatory response and myocardial injury in patients undergoing coronary artery bypass grafts. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70, 1443-1451. 100 + 0
https://dx.doi.org/10.1007/s00228-014-1751-5

59. Sari, A.; Korkmaz, B.; Serin, M.; Kacan, M.; Unsal, D.; Buharalioglu, C.; Firat, S.; Manthati, V.; Falck, J.; Malik, K. Effects of 5,14-HEDGE, a 20-HETE mimetic, on lipopolysaccharide-induced changes in MyD88/TAK1/IKK beta/I kappa B-alpha/NF-kappa B pathway and circulating miR-150, miR-223, and miR-297 levels in a rat model of septic shock. INFLAMMATION RESEARCH, 2014, 63, 741-756. 0 + 0
https://dx.doi.org/10.1007/s00011-014-0747-z

58. Tunctan, B. Inflammation and allergy. Editorial.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2014, 13, 1-2. 1000 + 0
2013
57. Tunctan, B. The latest advances in the use of conventional anti-inflammatory drugs and agents. Preface.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2013, 12, 1-1. 1000 + 15

Times Cited: 3
56. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; Sahan-firat, S.; Cuez, T.; Schunck, W. 5,14-HEDGE, a 20-HETE mimetic, reverses hypotension and improves survival in a rodent model of septic shock: Contribution of soluble epoxide:hydrolase, CYP2C23, MEK1/ERK1/2/IKK beta/IKB-alpha./NF-kappa B pathway, and proinflammatory. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 102, 31-41. 650 + 10
https://dx.doi.org/10.1016/j.prostaglandins.2013.01.005


Times Cited: 2
55. Tunctan, B.; Sari, A.; Kacan, M.; Unsal, D.; Buharalioglu, C.; Sahan-firat, S.; Korkmaz, B.; Falck, J.; Malik, K. NS-398 reverses hypotension in endotoxemic rats: Contribution of eicosanoids, NO, and peroxynitrite. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 2013, 104, 93-108. 700 + 0
https://dx.doi.org/10.1016/j.prostaglandins.2012.08.007

54. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; Sahan-firat, S.; Cuez, T.; Schunck, W. Contribution of iNOS/sGC/PKG pathway, COX-2, CYP4A1, and gp91(phox) to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against vasodilation, hypotension, tachycardia, and inflammation in a rat model of septic shock. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2013, 33, 18-41. 650 + 15
https://dx.doi.org/10.1016/j.niox.2013.05.001


Times Cited: 3
53. Battal, D.; Cok, I.; Unlusayin, I.; Aktas, A.; Tunctan, B. Determination of bisphenol A exposure in rural and urban areapopulations in Mersin City, Turkey. TOXICOLOGY LETTERS, 2013, 221, 103-103. 500 + 0
https://dx.doi.org/10.1016/j.toxlet.2013.05.154

2012
52. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Unsal, D.; Serin, M.; Buharalioglu, C.; Sahan-firat, S.; Schunck, W.; Falck, J. A novel treatment strategy for sepsis and septic shock based on the interactions between prostanoids, nitric oxide, and 20-hydroxyeicosatetraenoic acid.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 121-50. 650 + 25

Times Cited: 5
51. Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Demiryurek, A.; Sahan-firat, S.; Sari, A.; Tunctan, B. Contribution of MEK1/ERK1/2/iNOS pathway to oxidative stress and decreased caspase-3 activity in endotoxemic rats.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 243-52. 200 + 0
50. Sahan-firat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A.; Kacan, M.; Unsal, D.; Tunctan, B. Increased production of nitric oxide mediates selective organ-specific effects of endotoxin on oxidative stress.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 161-72. 100 + 0
49. Canacankatan, N.; Sucu, N.; Aytacoglu, B.; Gul, O.; Gorur, A.; Korkmaz, B.; Sahan-firat, S.; Antmen, E.; Tamer, L.; Ayaz, L. Affirmative Effects of Iloprost on Apoptosis during Ischemia-Reperfusion Injury in Kidney as a Distant Organ. RENAL FAILURE, 2012, 34, 111-118. 0 + 20
https://dx.doi.org/10.3109/0886022X.2011.633446


Times Cited: 4
48. Tunctan, B. Drug discovery and development.Preface.. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2012, 11, 1-1. 1000 + 0
2011
47. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Sahan-firat, S.; Sari, A.; Malik, K.; Tunctan, B. Piroxicam Reverses Endotoxin-Induced Hypotension in Rats: Contribution of Vasoactive Eicosanoids and Nitric Oxide. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2011, 109, 186-194. 200 + 25

Times Cited: 5
46. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Sahan-firat, S.; Sari, A.; Malik, K.; Tunctan, B. A SELECTIVE CYCLOOXYGENASE-1 INHIBITOR, PIROXICAM, REVERSES ENDOTOXIN-INDUCED HYPOTENSION IN RATS: CONTRIBUTION OF VASOACTIVE EICOSANOIDS AND NITRIC OXIDE. INFLAMMATION RESEARCH, 2011, 60, 150-151. 200 + 0
45. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C.; Sahan-firat, S.; Schunck, W.; Serin, M. CONTRIBUTION OF INOS, COX-2 AND CYP4A1 TO THE PROTECTIVE EFFECT OF A SYNTHETIC ANALOG OF 20-HETE, 5,14-HEDGE, AGAINST ENDOTOXIN-INDUCED HYPOTENSION AND MORTALITY IN EXPERIMENTAL MODEL OF SEPTIC SHOCK IN RATS AND MICE. INFLAMMATION RESEARCH, 2011, 60, 55-55. 650 + 15

Times Cited: 3
44. Korkmaz, B.; Buharalioglu, K.; Sahan-firat, S.; Cuez, T.; Demiryurek, A.; Tunctan, B. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway associated with peroxynitrite formation contributes to hypotension and vascular hyporeactivity. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2011, 24, 160-172. 400 + 50
https://dx.doi.org/10.1016/j.niox.2011.02.004


Times Cited: 10
43. Serin, M.; Tiftik, N.; Karakaya, B.; Tunctan, B.; Dogen, A.; Tezcan, S.; Kaplan, E.; Aslan, G.; Emekdas, G.; Yalcin, A. HIGH PREVALANCE OF ANTI-DENGUE VIRUS IGG IN PATIENTS WITH VENOUS THROMBOEMBOLISM AND POSSIBLE ROLE OF DENGUE VIRUS IN THROMBOSIS. INFLAMMATION RESEARCH, 2011, 60, 153-153. 350 + 0
2010
42. Tunctan, B.; Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Sahan-firat, S.; Falck, J.; Malik, K. Contribution of Vasoactive Eicosanoids and Nitric Oxide Production to the Effect of Selective Cyclooxygenase-2 Inhibitor, NS-398, on Endotoxin-Induced Hypotension in Rats. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 107, 877-882. 800 + 30
https://dx.doi.org/10.1111/j.1742-7843.2010.00589.x


Times Cited: 6
41. Cuez, T.; Korkmaz, B.; Buharalioglu, C.; Sahan-firat, S.; Falck, J.; Malik, K.; Tunctan, B. A Synthetic Analogue of 20-HETE, 5,14-HEDGE, Reverses Endotoxin-Induced Hypotension via Increased 20-HETE Levels Associated with Decreased iNOS Protein Expression and Vasodilator Prostanoid Production in Rats. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2010, 106, 378-388. 200 + 55
https://dx.doi.org/10.1111/j.1742-7843.2009.00501.x


Times Cited: 11
2009
40. Korkmaz, B.; Buharalioglu, K.; Demiryurek, A.; Sahan-firat, S.; Cuez, T.; Tunctan, B. Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway contributes to the fall in blood pressure and vascular reactivity in endotoxemic rats. FASEB JOURNAL, 2009, 23, 0-0. 400 + 0
39. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sahan-firat, S.; Yildirim, H.; Tamer, L.; Buharalioglu, K.; Falck, J.; Malik, K. Increased production of 20-HETE contributes to the effects of COX inhibitors to prevent the decrease in lipid peroxidation and increase in catalase activity during endotoxemia. FASEB JOURNAL, 2009, 23, 0-0. 700 + 0
38. Buharalioglu, K.; Ozbasoglu, O.; Korkmaz, B.; Cuez, T.; Sahan-firat, S.; Yalcin, A.; Tunctan, B. Thalidomide potentiates analgesic effect of COX inhibitors on endotoxin-induced hyperalgesia by modulating TNF-alpha, PGE and NO synthesis in mice. FASEB JOURNAL, 2009, 23, 0-0. 200 + 0
2008
37. Sahan-firat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A.; Tunctan, B. Differential regulation of oxidative stress by NO in vascular and nonvascular tissues of endotoxemic rats. FASEB JOURNAL, 2008, 22, 0-0. 100 + 0
36. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Firat, S.; Anjaiah, S.; Falck, J.; Roman, R.; Malik, K. A 20-hydroxyeicosatetraenoic acid agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the fall in blood pressure and vascular reactivity in endotoxin-treated rats. SHOCK, 2008, 30, 329-335. 750 + 95
https://dx.doi.org/10.1097/SHK.0b013e31816471c6


Times Cited: 19
35. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. ARCHIVES OF PHARMACAL RESEARCH, 2008, 31, 856-865. 950 + 40
https://dx.doi.org/10.1007/s12272-001-1238-x


Times Cited: 8
34. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Sahan-firat, S.; Anjaiah, S.; Falck, J.; Yildirim, H.; Tamer, L.; Roman, R.; Malik, K. 20-HETE agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the endotoxin-induced fall in blood pressure and the decrease in vascular reactivity and lipid peroxidation and increased catalase activity via inhibition of NO . FASEB JOURNAL, 2008, 22, 0-0. 650 + 0
2007
33. Tunctan, B.; Korkmaz, B.; Dogruer, Z.; Tamer, L.; Atik, U.; Buharalioglu, C. Inhibition of extracellular signal-regulated kinase (ERK1/2) activity reverses endotoxin-induced hypotension via decreased nitric oxide production in rats. PHARMACOLOGICAL RESEARCH, 2007, 56, 56-64. 850 + 45
https://dx.doi.org/10.1016/j.phrs.2007.03.006


Times Cited: 9
32. Gunaydin, B.; Sancak, B.; Candan, S.; Sariahmetoglu, M.; Ozcagli, G.; Tunctan, B.; Cakici, I.; Akcabay, M. Temporal variation of oxidant stress in critically ill patients. MINERVA ANESTESIOLOGICA, 2007, 73, 261-266. 250 + 15

Times Cited: 3
31. Uludag, O.; Tunctan, B.; Altug, S.; Zengil, H.; Abacioglu, N. Twenty-four-hour variation of L-arginine/nitric oxide/cyclic guanosine monophosphate pathway demonstrated by the mouse visceral pain model. CHRONOBIOLOGY INTERNATIONAL, 2007, 24, 413-424. 800 + 15
https://dx.doi.org/10.1080/07420520701420402


Times Cited: 3
2006
30. Korkmaz, B.; Ozveren, E.; Buharalioglu, C.; Tunctan, B. Extracellular signal-regulated kinase (ERK1/2) contributes to endotoxin-induced hyporeactivity via nitric oxide and prostacyclin production in rat aorta. PHARMACOLOGY, 2006, 78, 123-128. 650 + 30
https://dx.doi.org/10.1159/000095962


Times Cited: 6
29. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tamer, L.; Degirmenci, U.; Atik, U. Nitric oxide reverses endotoxin-induced inflammatory hyperalgesia via inhibition of prostacyclin production in mice. PHARMACOLOGICAL RESEARCH, 2006, 53, 177-192. 800 + 65
https://dx.doi.org/10.1016/j.phrs.2005.10.009


Times Cited: 13
28. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. NITRIC OXIDE-BIOLOGY AND CHEMISTRY, 2006, 14, 51-57. 950 + 65
https://dx.doi.org/10.1016/j.niox.2005.09.006


Times Cited: 13
27. Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tunctan, B. Involvement of calcium/calmodulin-dependent protein kinase II to endotoxin-induced vascular hyporeactivity in rat superior mesenteric artery. PHARMACOLOGICAL RESEARCH, 2006, 54, 208-218. 650 + 35
https://dx.doi.org/10.1016/j.phrs.2006.05.001


Times Cited: 7
26. Altug, S.; Uludag, O.; Tunctan, B.; Cakici, I.; Zengil, H.; Abacioglu, N. Biological time-dependent difference in effect of peroxynitrite demonstrated by the mouse hot plate pain model. CHRONOBIOLOGY INTERNATIONAL, 2006, 23, 583-591. 650 + 45
https://dx.doi.org/10.1080/07420520600650703


Times Cited: 9
2005
25. Tunctan, B.; Korkmaz, B.; Ozveren, E.; Buharalioglu, C. Mitogen-activated protein kinase signalling cascade contributes to endotoxin-induced hyporeactivity via nitric oxide and prostaglandin production in rat thoracic aorta. FASEB JOURNAL, 2005, 19, 1551-1551. 950 + 0
24. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C. Calcium/calmodulin dependent protein kinase II contributes to endotoxin-induced hyporeactivity via prostaglandin production in rat mesenteric artery. FASEB JOURNAL, 2005, 19, 1551-1551. 950 + 0
2004
23. Kiziltepe, U.; Tunctan, B.; Eyileten, Z.; Sirlak, M.; Arikbuku, M.; Tasoz, R.; Uysalel, A.; Ozyurda, U. Efficiency of L-arginine enriched cardioplegia and non-cardioplegic reperfusion in ischemic hearts. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2004, 97, 93-100. 650 + 75
https://dx.doi.org/10.1016/j.ijcard.2003.08.015


Times Cited: 15
22. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin induced hypotension in rats. FASEB JOURNAL, 2004, 18, 1037-1038. 950 + 0
21. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K. Prostagladins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. FASEB JOURNAL, 2004, 18, 1034-1035. 950 + 15

Times Cited: 3
2003
20. Tunctan, B.; Altug, S.; Uludag, O.; Demirkay, B.; Abacioglu, N. Effects of cyclooxygenase inhibitors on nitric oxide production and survival in a mice model of sepsis. PHARMACOLOGICAL RESEARCH, 2003, 48, 37-48. 900 + 80
https://dx.doi.org/10.1016/S1043-6618(03)00064-1


Times Cited: 16
2002
19. Tunctan, B.; Weigl, Y.; Dotan, A.; Peleg, L.; Zengil, H.; Ashkenazi, I.; Abacioglu, N. Circadian variation of nitric oxide synthase activity in mouse tissue. CHRONOBIOLOGY INTERNATIONAL, 2002, 19, 393-404. 800 + 115
https://dx.doi.org/10.1081/CBI-120002915


Times Cited: 23
18. Yurdakul, A.; Calisir, H.; Tunctan, B.; Ogretensoy, M. Comparison of second controller medications in addition to inhaled corticosteroid in patients with moderate asthma. RESPIRATORY MEDICINE, 2002, 96, 322-329. 750 + 135
https://dx.doi.org/10.1053/rmed.2002.1282


Times Cited: 27
2001
17. Abacioglu, N.; Tunctan, B.; Cakici, I.; Akbulut, E.; Uludag, O.; Kanzik, I. The role of L-arginine/nitric oxide pathway in the antinociceptive activity of pyridoxine in mouse. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51, 832-838. 750 + 45

Times Cited: 9
16. Abacioglu, N.; Ozmen, R.; Cakici, I.; Tunctan, B.; Kanzik, I. Role of L-arginine/nitric oxide pathway in the antinociceptive activities of morphine and mepyramine in mice. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2001, 51, 977-983. 600 + 60

Times Cited: 12
2000
15. Abacioglu, N.; Demir, S.; Cakici, I.; Tunctan, B.; Kanzik, I. Role of guanylyl cyclase activation via thiamine in suppressing chemically-induced writhing in mouse. ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2000, 50, 554-558. 600 + 50

Times Cited: 10
14. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N. Time-dependent variations in serum nitrite, 6-keto-prostaglandin F-1 alpha and thromboxane B-2 levels induced by lipopolysaccharide in mice. BIOLOGICAL RHYTHM RESEARCH, 2000, 31, 499-513. 950 + 50
https://dx.doi.org/10.1076/0929-1016(200010)31:4;1-2;FT499


Times Cited: 10
13. Hosgor-basgut, B.; Basgut, E.; Soyak, G.; Tunctan, B.; Cakici, F.; Kanzik, I. Peroxynitrite produces relaxations on the rat anococcygeus muscle. LIFE SCIENCES, 2000, 67, 3123-3127. 550 + 10
https://dx.doi.org/10.1016/S0024-3205(00)00886-9


Times Cited: 2
12. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N. Effects of econazole on receptor-operated and depolarization-induced contractions in rat isolated aorta. LIFE SCIENCES, 2000, 67, 2393-2401. 950 + 35
https://dx.doi.org/10.1016/S0024-3205(00)00822-5


Times Cited: 7
11. Abacioglu, N.; Tunctan, B.; Akbulut, E.; Cakici, I. Participation of the components of L-arginine/nitric oxide/cGMP cascade by chemically-induced abdominal constriction in the mouse. LIFE SCIENCES, 2000, 67, 1127-1137. 850 + 150
https://dx.doi.org/10.1016/S0024-3205(00)00711-6


Times Cited: 30
1999
10. Uludag, O.; Tuncan, B.; Guney, H.; Uluoglu, C.; Altug, S.; Zengil, H.; Abacioglu, N. Temporal variation in serum nitrite levels in rats and mice. CHRONOBIOLOGY INTERNATIONAL, 1999, 16, 527-532. 0 + 25
https://dx.doi.org/10.3109/07420529908998726


Times Cited: 5
1998
9. Tunctan, B.; Cakici, I.; Abacioglu, N.; Kanzik, I. Bradykinin-induced responses in a coaxial bioassay system composed of rat anococcygeus muscle and guinea pig trachea. GENERAL PHARMACOLOGY, 1998, 30, 477-482. 950 + 5
https://dx.doi.org/10.1016/S0306-3623(97)00104-3


Times Cited: 1
8. Tunctan, B.; Uludag, O.; Altug, S.; Abacioglu, N. Effects of nitric oxide synthase inhibition in lipopolysaccharide-induced sepsis in mice. PHARMACOLOGICAL RESEARCH, 1998, 38, 405-411. 950 + 245
https://dx.doi.org/10.1006/phrs.1998.0381


Times Cited: 49
7. Tunctan, B.; Okur, H.; Calisir, C.; Abacioglu, H.; Cakici, I.; Kanzik, I.; Abacioglu, N. Comparison of nitric oxide production by monocyte/macrophages in healthy subjects and patients with active pulmonary tuberculosis. PHARMACOLOGICAL RESEARCH, 1998, 37, 219-226. 800 + 55
https://dx.doi.org/10.1006/phrs.1997.0284


Times Cited: 11
6. Guney, H.; Gorgun, C.; Tunctan, B.; Uludag, O.; Hodoglugil, U.; Abacioglu, N.; Zengil, H. Circadian-rhythm-dependent effects of L-N-G-nitroarginine methyl ester (L-NAME) on morphine-induced analgesia. CHRONOBIOLOGY INTERNATIONAL, 1998, 15, 283-289. 600 + 65
https://dx.doi.org/10.3109/07420529808998690


Times Cited: 13
1997
5. Cakici, I.; Ulug, H.; ınci, S.; Tunctan, B.; Abacioglu, N.; Kanzik, I.; Sener, B. Antinociceptive effect of some amaryllidaceae plants in mice. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1997, 49, 828-830. 500 + 30

Times Cited: 6
1995
4. Cakıcı, I.; Mataracı, N.; Ersoy, S.; Tunctan, B.; Abacıoglu, N.; Kanzık, I. EFFECTS OF PLATELET-ACTIVATING-FACTOR ANTAGONISTS WEB-2086 AND BN-50730 ON DIGOXIN-INDUCED ARRHYTHMIAS. PHARMACOLOGY & TOXICOLOGY, 1995, 76, 343-347. 550 + 15

Times Cited: 3
1994
3. Cakıcı, I.; Hurmoglu, C.; Tunctan, B.; Abacıoglu, N.; Kanzık, I.; Sener, B. HYPOGLYCEMIC EFFECT OF MOMORDICA-CHARANTIA EXTRACTS IN NORMOGLYCEMIC OR CYPROHEPTADINE-INDUCED HYPERGLYCEMIC MICE. JOURNAL OF ETHNOPHARMACOLOGY, 1994, 44, 117-121. 650 + 145
https://dx.doi.org/10.1016/0378-8741(94)90077-9


Times Cited: 29
1993
2. Cakıcı, I.; Tunctan, B.; Abacıoglu, N.; Kanzık, I. EPITHELIUM-DEPENDENT RESPONSES OF SEROTONIN IN A COAXIAL BIOASSAY SYSTEM. EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 236, 97-105. 850 + 20
https://dx.doi.org/10.1016/0014-2999(93)90231-6


Times Cited: 4
1. Abacıoglu, N.; Bedız, A.; Cakıcı, I.; Tunctan, B.; Kanzık, I. ANTINOCICEPTIVE EFFECTS OF H1-ANTIHISTAMINICS AND H2-ANTIHISTAMINICS IN MICE. GENERAL PHARMACOLOGY, 1993, 24, 1173-1176. 600 + 40
https://dx.doi.org/10.1016/0306-3623(93)90365-5


Times Cited: 8
International - Covered by Other International Indexes 850
2016
5. Senol, S.; Tiftik, E.; Unal, S.; Akdeniz, A.; Tasdelen, B.; Tunctan, B. Quality of life, clinical effectiveness, and satisfaction in patients with beta thalassemia major and sickle cell anemia receiving deferasirox chelation therapy. JOURNAL OF BASIC AND CLINICAL PHARMACY, 2016, 7, 49-59. 80 + 0
Publications_001.pdf

2015
4. Tunctan, B. An overview of published papers and important developments in the past three years. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY, 2015, 14, 2-12. 200 + 0
2013
3. Tunctan, B. 20-HETE mimetics or inhibitors in the treatment of cancer patients with sepsis and septic shock. INTERNATIONAL JOURNALS OF CANCER STUDIES & RESEARCH , 2013, 2, 101-108. 200 + 0
2005
2. Tunctan, B.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Atik, U.; Buharalioglu, C. Increased production of nitric oxide contributes to renal oxidative stress in endotoxemic rat. AMERICAN JOURNAL OF INFECTIOUS DISEASES , 2005, 1, 111-115. 170 + 0
2004
1. Tunctan, B.; Altug, S. The use of nitric oxide synthase inhibitors in inflammatory diseases: a novel class of anti-inflammatory agents. CURRENT MEDICINAL CHEMISTRY: ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS , 2004, 3, 271-301. 200 + 0
National - Covered by ULAKBIM 2460
2017
16. Küçük, M.; Karaca, K.; Fırat, S.; Vezir, .; Canacankatan, N.; Aytaçoğlu, B.; Erden, S.; Tunçtan, B.; Sucu, N. Koroner arter bypass cerrahisinde ramiprilin miyokardiyal hasar ve inflamatuvar yanıttaki etkisi üzerinde sitokin gen polimorfizmlerinin rolü. CUKUROVA MEDICAL JOURNAL, 2017, 42, 436-445. 20 + 0
http://dx.doi.org/10.17826/cutf.323386

2015
15. şenol, .; Tunçtan, B. The role of peroxisome proliferator-activated receptors in the pathogenesis of insulin resistance and septic shock. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2015, 5, 247-258. 200 + 0
14. Güden, D.; Temiz, M.; Tunçtan, B.; şahan fırat, S. Sepsis ve septik şok patojenezinde endotelin-1'in rolü ve tedavide yeni yaklaşımlar. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2015, 5, 178-190. 150 + 0
2014
13. Güden, D.; Tunçtan, B. The role of endothelin-1 in the pathogenesis of diabetes. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2014, 4, 158-167. 200 + 0
12. ünsal, D.; Temiz, M.; Tunçtan, B.; şahan-fırat, S. Signal transduction of zymosan and spleen tyrosine kinase. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI, 2014, 4, 148-157. 150 + 0
2010
11. Sarı, A.; şahan-fırat, S.; Tunçtan, B. Rho kinase and cardiovascular diseases. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , 2010, 3, 1-7. 200 + 0
2008
10. şahan-fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Sarı, A.; Tunçtan, B. Effect of inhibition of inducible nitric oxide synthase on the increased oxidative stress in the liver of endotoxemic rats. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , 2008, 1, 28-35. 40 + 0
2006
9. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N. Contribution of nitric oxide and tumor necrosis factor-a to the effect of indomethacin on the endotoxin-induced mortality. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , 2006, 30, 1-6. 190 + 0
2005
8. Tunctan, B. Nitric oxide decreases eicosanoid production via activation of guanylyl cyclase and polyADP-ribose synthase in endotoxin-stimulated whole blood, kidney and heart. TURKISH JOURNAL OF PHARMACEUTICAL SCIENCES, 2005, 2, 137-154. 200 + 0
7. Tunçtan, B.; Buharalıoğlu, C. Pharmacological Terminology Dictionary. SENDROM III, 2005, 3, 3-44. 200 + 0
2004
6. Tunçtan, B.; Aykanat, D.; Korkmaz, B.; özveren, E.; Buharalıoğlu, C. Euthanasia methods for experimental animals. MERSIN UNIVERSITESI TIP FAKULTESI DERGISI , 2004, 1, 44-54. 180 + 0
2003
5. Kızıltepe, U.; Taşöz, R.; Aral, A.; Tunçtan, B.; Eyileten, Z.; şırlak, M.; Emiroğulları, O.; Arıkbuku, M.; Eryılmaz, S.; Yazıcıoğlu, L. Efficiency of L-arginine cardioplegia and L-arginine supplemented non-cardiopegic blood in preventing of controlled reperfusions. MEDIKAL NETWORK KARDIYOLOJI , 2003, 10, 33-40. 70 + 0
2002
4. Taşöz, R.; Kızıltepe, U.; Eyileten, Z.; Tunçtan, B.; şırlak, M.; Emiroğulları, O.; Eryılmaz, S.; Yazıcıoğlu, L.; Aral, A.; Eren, N. Myocardial nitric oxide metabolism and possible treatment options in open thoracic surgery. MEDIKAL NETWORK KARDIYOLOJI , 2002, 9, 345-351. 70 + 0
2000
3. Tunçtan, B. Role of nitric oxide synthase inhibitors in septic shock teatment. ILAC VE TEDAVI DERGISI, 2000, 13, 298-307. 200 + 0
1998
2. Tunçtan, B.; Abacıoğlu, N. Measurement of nitric oxide in biological samples: diazotization method. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES, 1998, 23, 161-170. 200 + 0
1993
1. Tunçtan, B.; çakıcı, .; Abacıoğlu, N.; Kanzık, . Epithelium-derived relaxant factors and bronchial hypereactivity. FABAD JOURNAL OF PHARMACEUTICAL SCIENCES , 1993, 18, 71-76. 190 + 0
National - Other 50
2017
2. Küçükkavruk, .; Tunçtan, B. ---. TURK FARMAKOLOJI DERNEGI BULTENI, 2017, 136, 16-21. 50 + 0
2016
1. şenol, . Myocardial and renal ischemia/reperfusion injury and experimental models. TURKIYE KLINIKLERI ECZACILIK BILIMLERI DERGISI, 2016, 5, 93-109. 0 + 0
http://www.turkiyeklinikleri.com/journal/eczacilik-bilimleri-dergisi/2146-944X/

International - Chapter(s) in Book 1000
1. Tunctan, B. Nitric Oxide Synthase Inhibitors: From Animal Studies to Clinical Implications, ISBN: 978-81-7895-534-6 , Transworld Research Network, Number of print: 1000, Total Printing Number: 1, 8 Page, English, Kerala, India, 2012. 250
2. Tunctan, B. Nitric Oxide Synthase Inhibitors: From Animal Studies to Clinical Implications, ISBN: 978-81-7895-534-6 , Transworld Research Network, Number of print: 1, Total Printing Number: 1000, 96 Page, English, Kerala, India, 2012. 500
International - Book Edited 1000
1. Tunctan, B. Nitric Oxide Synthase Inhibitors: From Animal Studies to Clinical Implications, ISBN: 978-81-7895-534-6, Transworld Research Network, Number of print: 1, Total Printing Number: 1000, 250 Page, English, Kerala, India, 2012. 250
National - Book 4895
1. Yeşilada, E.; Zülfikar, H.; Ertan, R.; Yakıncı, C.; Tunçtan, B.; Aktay, G.; özkan, Y.; Aydın, A.; Küçükgüzel, .; Savaşer, A. Drug and Pharmacy Terms Dictionary, ISBN: 978-975-16-2838-1, Ertem Basım Yayın Dağıtım, Number of print: 2, Total Printing Number: 2000, 1032 Page, Turkish, Ankara, Turkey, 2015. 45
2. Tunçtan, B. Rational Drug Use in Pediatric Patients, ISBN: 978-605-60137-6-8 , Türk Eczacıları Birliği Eczacılık Akademisi, Yorum Matbaacılık, Number of print: 1, Total Printing Number: 1000, 120 Page, Turkish, Ankara, Turkey, 2012. 500
3. Yeşilada, E.; Zülfikar, H.; Ertan, R.; Yakıncı, C.; Tunçtan, B.; Aktay, G.; özkan, Y.; Aydın, A.; Küçükgüzel, .; Savaşer, A. Drug and Pharmacy Terms Dictionary, ISBN: 978-975-16-2838-1, Atatürk Kültür, Dil ve Tarih Yüksek Kurumu Türk Dil Kurumu, Ertem Basım Yayın Dağıtım, Number of print: 1, Total Printing Number: 2000, 1001 Page, Turkish, Ankara, Turkey, 2014. 50
National - Chapter(s) in Book 4895
1. Tunçtan, B. Guideline for Pharmacists, ISBN: 978-975-8037-39-1, Fersa Ofset, Number of print: 1, Total Printing Number: 1100, 500 Page, Turkish, Ankara, Turkey, 2015. 0
2. Tunçtan, B. Preventive Health Guide, ISBN: 978-605-60137-5-1, Türk Eczacıları Birliği Eczacılık Akademisi, Mattek Matbaacılık Bas. Yay. Tan San. Tic. Ltd. Şti., Number of print: 2, Total Printing Number: 1000, 7 Page, Turkish, Ankara, Turkey, 2012. 4000
3. Buharalıoğlu, K.; Tunçtan, B. Medication Skill, ISBN: 978-605-60137-9-9, Türk Eczacıları Birliği Eczacılık Akademisi, Yorum Matbaacılık, Number of print: 1, Total Printing Number: 1000, 2 Page, Turkish, Ankara, Turkey, 2013. 0
4. Tunçtan, B. Preventive Health Guide, ISBN: 978-605-60137-5-1, Mattek Matbaacılık Bas. Yay. Tan San. Tic. Ltd. Şti., Number of print: 2, Total Printing Number: 1000, 768 Page, Turkish, Ankara, Turkey, 2014. 0
5. Tunçtan, B. Guideline for Pharmacists, ISBN: 978-975-8037-39-1, Türk Eczacıları Birliği Eczacılık Akademisi Yayını, Özyurt Matbaacılık, Number of print: 2, Total Printing Number: 25000, 528 Page, Turkish, Ankara, Turkey, 2016. 250
National - Chaper(s) in Book (Translated) 4895
1. Tunçtan, B. Goodman and Gilman's Manual of Pharmacology and Therapeutics, ISBN: 978-975-277-676-0, Güneş Tıp Kitabevleri, Number of print: 2, Total Printing Number: 5000, 1220 Page, Turkish, Ankara, Turkey, 2017. 50
International - SCI/SCI-Exp. indexed - Oral 575

2. Battal, D.; Cok, I.; Unlusayin, I.; Aktas, A.; Tunctan, B., Determination of bisphenol A exposure in rural and urban area populations in Mersin City. The 49th Congress of the European Societes of Toxicology (EUROTOX), 2013-09-01, 2013-09-04, Interlaken, Switzerland, 2013. 250

1. Tunctan, B.; Korkmaz, B.; Cuez, T.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C., Contribution of iNOS, COX-2 and CYP4A1 to the protective effect of a synthetic analog of 20-HETE, 5,14-HEDGE, against endotoxin-induced hypotension and mortality in experimental model of septic shock in rats and mice. 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 325

International - SCI/SCI-Exp. indexed - Poster 3137

20. Buharalioglu, C.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Sari, A.; Malik, K.; Tunctan, B., A selective cyclooxygenase-1 inhibitor, piroxicam, reverses endotoxin-induced hypotension in rats: contribution of vasoactive eicosanoids and nitric oxide. 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 50

19. Serin, M.; Tiftik, N.; Karakaya, B.; Tunctan, B.; Dogen, A.; Tezcan, S.; Kaplan, E., High prevalance of anti-dengue virus IGG in patients with venous thromboembolism and possible role of dengue virus in thrombosis. 10th World Congress on Inflammation, 2011-06-25, 2011-06-29, Paris, France, 2011. 87

18. Sahan-Firat, S.; Korkmaz, B.; Cuez, T.; Ayaz, L.; Tamer, L.; Buharalioglu, C.; Sari, A., Prostaglandins contribute to endotoxin-induced increase in lipid peroxidation via nitric oxide production during endotoxemia in rats. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 25

17. Korkmaz, B.; Buharalioglu, K.; Demiryurek, T.; Sahan-Firat, S.; Cuez, T.; Tunctan, B., Activation of MEK1/ERK1/2/iNOS/sGC/PKG pathway contributes to the fall in blood pressure and vascular reactivity in endotoxemic rats. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 100

16. Tunctan, B.; Kormaz, B.; Cuez, T.; Sahan-Firat, S.; Yildirim, H.; Tamer, L.; Buharalioglu, K., Increased production of 20-HETE contributes to the effects of COX inhibitors to prevent the decrease in lipid peroxidation and increase in catalase activity during endotoxemia. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 175

15. Buharalioglu, K.; Ozbasoglu, O.; Korkmaz, B.; Cuez, T.; Sahan-Firat, S.; Yalcin, A.; Tunctan, B., Thalidomide potentiates analgesic effect of COX inhibitors on endotoxin-induced hyperalgesia by modulating TNF-a, PGE and NO synthesis in mice. Experimental Biology 2009, 2009-04-18, 2009-04-22, New Orleans, United States of America, 2009. 50

14. Sahan-Firat, S.; Canacankatan, N.; Korkmaz, B.; Yildirim, H.; Tamer, L.; Buharalioglu, C.; Sari, A., Differential regulation of oxidative stress by NO in vascular and nonvascular tissues of endotoxemic rats. Experimental Biology 2008, 2008-04-05, 2008-04-09, San Diego, United States of America, 2008. 25

13. Tunctan, B.; Korkmaz, B.; Buharalioglu, C.; Sahan-Firat, S.; Anjaiah, S.; Falck, J.; Yildirim, H., 20-HETE agonist, N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine, opposes the endotoxin-induced fall in blood pressure and the decrease in vascular reactivity and lipid peroxidation and increased catalase activity via inhibition of NO production in rats. Experimental Biology 2008, 2008-04-05, 2008-04-09, San Diego, United States of America, 2008. 162

12. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C., Calcium/calmodulin dependent protein kinase II contributes to endotoxin-induced hyporeactivity via prostaglandin production in rat mesenteric artery. Experimental Biology 2005, 2005-03-31, 2005-04-05, San Diego, United States of America, 2005. 237

11. Tunctan, B.; Korkmaz, B.; Ozveren, E.; Buharalioglu, C., Mitogen-activated protein kinase signalling cascade contributes to endotoxin-induced hyporeactivity via nitric oxide and prostaglandin production in rat thoracic aorta. Experimental Biology 2005, 2005-03-31, 2005-04-05, San Diego, United States of America, 2005. 237

10. Tunctan, B.; Yaghini, A.; Estes, A.; Malik, K., Inhibition by nitric oxide of cytochrome P450 4A activity contributes to endotoxin-induced hypotension in rats. Experimental Biology 2004, 2004-04-17, 2004-04-21, Washington , United States of America, 2004. 237

9. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K., Prostaglandins inhibit cytochrome P450 4A activity and contribute to endotoxin-induced hypotension in rats via nitric oxide production. Experimental Biology 2004, 2004-04-17, 2004-04-21, Washington , United States of America, 2004. 237

8. Soyak, G.; Hosgor, B.; Ademoglu, F.; Tunctan, B.; Cakici, I.; Zengil, H.; Abacioglu, N., Chrononociceptive pattern of melatonin with the interaction of morphine and L-nitroarginine methyl ester (L-NAME). Biological Rhythms and Medications Joint Meeting of The Eight International Conference of Chronopharmacology and Chronotherapeutics and The American Association for Medical Chronobiology and Chronotherapeutics, 1999-08-24, 1999-08-28, Williamsburg, United States of America, 1999. 125

7. Tunctan, B.; Weigl, Y.; Dotan, A.; Peleg, L.; Zengil, H.; Ashkenazi, I.; Abacioglu, N., Circadian variation of nitric oxide synthase activity in mice kidney, testis, aorta and lungs. Biological Rhythms and Medications Joint Meeting of The Eight International Conference of Chronopharmacology and Chronotherapeutics and The American Association for Medical Chronobiology and Chronotherapeutics, 1999-08-24, 1999-08-28, Williamsburg, United States of America, 1999. 200

6. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N., Effects of econazole on receptor-operated and depolarization-induced contractions in rat isolated aorta. 2nd European Congress of Pharmacology, 1999-07-03, 1999-07-07, Budapest, Hungary, 1999. 237

5. Tunctan, B.; Weigl, Y.; Peleg, L.; Zengil, H.; Ashkenazi, I.; Abacioglu, N., Circadian variation of nitric oxide synthase activity in mice brain. 2nd European Congress of Pharmacology, 1999-07-03, 1999-07-07, Budapest, Hungary, 1999. 212

4. Hosgor, B.; Basgut, E.; Soyak, G.; Tunctan, B.; Cakici, I.; Kanzik, I., Effects of peroxynitrite and 3-nitro-L-tyrosine on the rat anococcygeus muscle. Fourth European Congress of Pharmaceutical Sciences, 1998-09-11, 1998-09-13, Milan, Italy, 1998. 137

3. Abacioglu, N.; Zengil, H.; Uludag, O.; Tunctan, B.; Guney, Z., Chronorhythmicity of L-arginine in nociception with the interaction of H1-receptor blocker mepyramine. International Congress of Chronobiology, 1997-09-07, 1997-09-11, Paris, France, 1997. 150

2. Tunctan, B.; Cakici, I.; Abacioglu, N.; Kanzik, I., Epithelium-dependent responses of bradykinin in a co-axial bioassay system. Annual Congress of European Respiratory Society , 1993-09-25, 1993-09-29, Firenze, Italy, 1993. 237

1. Abacioglu, N.; Tunctan, B.; Cakici, I.; Kanzik, I., Effects of ovalbumin challenge on epithelium-dependent responses to serotonin in a co-axial bioassay system. Annual Congress of European Respiratory Society, 1992-08-29, 1992-09-03, Vienna, Austria, 1992. 212

International - Full text - Oral 320

2. GUDEN, D.; TEMIZ-RESITOGLU, M.; KÜÇÜKKAVRUK, S.; TUNCTAN, B.; ŞAHAN-FIRAT, S., Protective effect of mTOR inhibition on LPS-induced systemic inflammation and tissue injury: contribution of mTOR/IκB-α/NF-κB/HIF-1α signaling pathway and NADPH oxidase system activity. 12th International Symposium on Pharmaceutical Sciences (ISOPS), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 120

1. TUNÇTAN, B., Transcription factors and CYP-derived eicosanoids as therapeutic targets in cardiovascular and renal inflammatory response caused by endotoxemia . PCS 2nd Annual World Congress of Cardiothoracic-Renal Diseases (WCCRD-2015), 2015-10-30, 2015-10-31, Varşova, Poland, 2015. 200
http://www.pcscongress.com/wccrd2015

International - Abstract - Oral 855

11. GUDEN, D.; TEMIZ-RESITOGLU, M.; SENOL, S.; KIBAR, D.; YILMAZ, S.; TUNCTAN, B.; SAHAN-FIRAT, S., mTOR contributes to LPS-triggered neuroinflammation: Modulation of IκB-α/NF-κB/HIF-1α signaling pathway. 21st Annual Meeting of the German Society for Experimental and Clinical Pharmacology and Toxicology (DGPT) and the 21st Annual Meeting of the Association of the Clinical Pharmacology Germany (VKliPha), 2019-02-25, 2019-02-28, Stuttgart, Germany, 2019. 30

10. TAŞDELEN, B.; TUNCTAN, B., Gözlemsel klinik çalışma tasarlarken dikkat edilmesi gereken hususlar. 17. Uluslararası Doğu Akdeniz Aile Hekimliği Kongresi - DAAHK, 2018-05-10, 2018-05-13, Adana, Turkey, 2018. 100

9. ŞAHAN FIRAT, S.; KOÇAK, Z.; TEMİZ-REŞİTOĞLU, M.; GÜDEN, D.; VEZİR, Ö.; SUCU, N.; BALCI, Ş., Role of mTOR/IκB-α/NF-κB pathway activation in ischemia/reperfusion-induced inflammatory response in rats. Pharmacology 2017, 2017-12-11, 2017-12-13, Londra, England / United Kingdom, 2017. 10

8. Tunctan, B.; Kucukkavruk, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S.; Paudyal, P., Contribution of NLRP3 inflammasome to the protective effect of 5,14-HEDGE, a 20-HETE mimetic, against LPS-induced septic shock in rats. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Amsterdam, Netherlands, 2017. 70
Scientific_Meetings_005.pdf

7. Tunctan, B.; Kucukkavruk, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S., Protective effect of bexarotene, a selective RXRa agonist, against hypotension associated with inflammation and tissue injury linked to decreased circulating inos levels in a rat model of septic shock. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Amsterdam, Netherlands, 2017. 85
Scientific_Meetings_004.pdf

6. Tunçtan, B.; Dolunay, A.; Senol, S.; Temiz Resitoglu, M.; Guden, D.; Sari, A.; Sahan Firat, S., Inhibition of NLRP3 inflammasome prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice: contribution of NF-B, caspase-1/11, ASC, NADPH oxidase, and NOS isoforms. 7th European Congress of Pharmacology (EPHAR2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 80
http://ephar2016.org/

5. TUNÇTAN, B., Targeting miRNAs in the treatment of cardiovascular and renal diseases . 7th European Congress of Pharmacology (EPHAR2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 100
http://www.ephar2016.org/

4. Tunctan, B., Transcription factors and CYP-derived eicosanoids as therapeutic targets in cardiovascular and renal inflammatory response caused by endotoxemia. CS World Congress of Cardiothoracic-Renal Diseases-2015, 2015-10-30, 2015-10-31, Warsaw, Poland, 2015. 100

3. Tunctan, B.; Korkmaz, B.; Cuez, T.; Buharalioglu, C.; Sahan-Firat, S.; Falck, J.; Malik, K., Interactions between cytochrome P4504A, cyclooxygenase and nitric oxide synthase during endotoxemia: therapeutic implications for inflammatory diseases. EHRLICH II - 2nd World Conference on Magic Bullets, Celebrating the 100th Anniversary of the Nobel Prize Award to Paul Ehrlich, 2008-10-03, 2008-10-05, Nurnberg, Germany, 2008. 80

2. Tunctan, B., Interactions between cyclooxygenase and nitric oxide synthase pathway: implications for therapeutic intervention in inflammatory diseases. II. Mediterranean Pharmacy Congress, 2006-10-13, 2006-10-15, Mersin, Turkey, 2006. 100

1. Tunctan, B., Role of a pharmacist in clinical research. I. International Mediterranean Pharmacy Congress, 2005-10-28, 2005-10-31, Mersin, Turkey, 2005. 100

International - Abstract - Poster 632

27. Cagli, A.; Senol, S.; Temiz-Resitoglu, M.; Guden, D.; Sari, A.; Sahan-Firat, S.; Tunctan, B., Inhibition of soluble epoxide hydrolase prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice: Contribution of NLRC4 Inflammasome, NLRC3, NOX, iNOS, and nNOS. Pain in Europe XI - the 11th Congress of the European Pain Federation EFIC, 2019-09-04, 2019-09-07, Valencia, Spain, 2019. 10
https://efic-congress.org/

26. KUCUKKAVRUK, S.; TEMIZ-RESITOGLU, M.; GUDEN, D.; SARI, A.; SAHAN-FIRAT, S.; TUNÇTAN, B., Bexarotene, a RXRα agonist, prevents lipopolysaccharide-induced inflammatory hyperalgesia in mice. 12th International Symposium on Pharmaceutical Sciences (ISOPS), 2018-06-26, 2018-06-29, Ankara, Turkey, 2018. 20

25. GÜDEN, D.; KOÇAK, Z.; TEMİZ-REŞİTOĞLU, M.; VEZİR, Ö.; SUCU, N.; BALCI, Ş.; TAMER GÜMÜŞ, L., Contribution of mTOR to oxidative stress leading to organ injury in a rat model of hindlimb ischemia/reperfusion. Pharmacology 2017, 2017-12-11, 2017-12-13, Londra, England / United Kingdom, 2017. 5

24. ŞAHAN FIRAT, S.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; KÜÇÜKKAVRUK, Ş.; TUNÇTAN, B.; SARI, A.; KOÇAK, Z., Activation of mTOR/MEK1/ERK1/2/IKKβ/IκB-α//NF-ĸB p65 pathway contributes to zymosan-induced systemic inflammatory response in rats. 2nd International Gazi Pharma Symposium Series (GPSS-2017), 2017-10-11, 2017-10-13, ANKARA, Turkey, 2017. 20

23. Battal, D.; Çok, İ.; Aktaş Şüküroğlu, A.; Ünlüsayın, İ.; Tunçtan, B., Exposure of the Turkish population to bisphenol A, 4-t-octylphenol and 4-nonylphenol and: a pilot study. 2nd International Gazi Pharma Symposium Series (GPSS-2017), 2017-10-11, 2017-10-13, Ankara, Turkey, 2017. 25

22. TUNÇTAN, B.; KUCUKKAVRUK, S.; TETEMIZ-RESITOGLU, M.; GUDEN, D.; SARI, A.; SAHAN-FIRAT, S., Bir sıçan septik şok modelinde seçici bir RXRa agonisti olan beksaroten PPARa/b/g-RXRa heterodimerlerinin oluşumundaki artmanın aracılık ettiği enflamasyon ve doku zedelenmesi ile birlikte olan hipotansiyonu geri çevirmektedir. . 17th Congress of European Shock Society: numerous "premières", 2017-09-13, 2017-09-15, Paris, France, 2017. 42
http://www.essparis2017.org/#overview

21. Sahan Firat, S.; Temiz-Resitoglu, M.; Guden, D.; Kucukkavruk, S.; Tunctan, B.; Sari, A.; Kocak, Z., Contribution of mTOR to Oxidative/Nitrosative Stress via NADPH Oxidase System Activation in Zymosan-Induced Systemic Inflammation in Rats. ICI 2017: 19th International Conference on Inflammation, 2017-05-14, 2017-05-15, Amsterdam, Netherlands, 2017. 20
Scientific_Meetings_006.pdf

20. Sahan Firat, S.; Temiz Resitoglu, M.; Buharalioglu, C.; Guden, D.; Senol, S.; Sari, A.; Kacan, M., The role of IkB-a/NF-kB pathway activation in hypotension and inflammation reversed by BAY 61-3606, a selective Syk inhibitor, in rat models of septic and non-septic shock. 7th European Congress of Pharmacology (EPHAR2016), 2016-06-26, 2016-06-30, İstanbul, Turkey, 2016. 5
http://ephar2016.org/

19. Temiz, M.; Senol, S.; Guden, D.; Cecen, P.; Sari, A.; Tunctan, B.; Gorur, A., Inhibition of mammalian target of rapamycin reverses lipopolysaccharide-induced hypotension and inflammation in rats. 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 7

18. Canacankatan, N.; Yilmaz, N.; Sucu, N.; Gul, O.; Gorur, A.; Aytacoglu, B.; Korkmaz, B., Effect of iloprost, a prostacyclin derivate on apoptosis during ischemia-reperfusion injury in lung as a distant organ. 11th International Symposium on Pharmaceutical Sciences (ISOPS-11), 2015-06-09, 2015-06-12, Ankara, Turkey, 2015. 5

17. Tunctan, B.; Korkmaz, B.; Sari, A.; Kacan, M.; Gilik, D.; Serin, M.; Buharalioglu, C., A synthetic analog of 20-HETE, 5,14-HEDGE, reverses endotoxin-induced hypotension and mortality via increased expression and activities of CYP4A1 and CYP2C23 in a rodent model of septic shock: contribution of MEK1/ERK1/2/IKK/IB-/NF-B pathway and soluble epoxide hydrolase. The 1st Central and Eastern European Conference on Sepsis, the SepsEast 2012, 2012-09-19, 2012-09-23, Budapest, Hungary, 2012. 32

16. Canacankatan, N.; Sucu, N.; Gul, O.; Gorur, A.; Aytacoglu, B.; Korkmaz, B.; Sahan-Firat, S., Iloprost, a prostacyclin analogue prevents limb ischemia-reperfusion injury by reducing apoptosis in rats. 10th International Symposium on Pharmaceutical Sciences (ISOPS-10), 2012-06-26, 2012-06-29, Ankara, Turkey, 2012. 5

15. Tunctan, B.; Sari, A.; Kacan, M.; Gilik, D.; Buharalioglu, C.; Sahan-Firat, S.; Korkmaz, B., NS-398, a selective COX-2 inhibitor, reverses endotoxin-induced hypotension via increased CYP4A1 expression and 20-HETE levels associated with decreased COX-2 and iNOS expression and/or activity in a rat model of septic shock. The 14th International Winter Eicosanoid Conference, 2012-03-11, 2012-03-14, Baltimore, United States of America, 2012. 35

14. Canacankatan, N.; Sucu, N.; Sahan-Firat, S.; Gorur, A.; Antmen, S.; Korkmaz, B.; Tunctan, B., Attenuation of ischemia-reperfusion injury by iloprost on apoptosis and antioxidant capacity in kidney as a distant organ. 3rd International Congress on Cell Membranbes and Oxidative Stress: Focus on Calcium Signalling and TRP Channels, 2010-06-22, 2010-06-27, Isparta, Turkey, 2010. 5

13. Korkmaz, B.; Cuez, T.; Sahin, N.; Tunctan, B., Analgesic activity of solid dispersions of ibuprofen. II. Mediterranean Pharmacy Congress, 2006-10-13, 2006-10-15, Mersin, Turkey, 2006. 32

12. Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tunctan, B., Inhibition of inducible nitric oxide synthase restores attenuation of endothelium-dependent and endothelium-independent relaxations in rat superior mesenteric artery exposed to endotoxin. 8th International Symposium on Pharmaceutical Sciences (ISOPS-8), 2006-06-13, 2006-06-16, Ankara, Turkey, 2006. 32

11. Kiziltepe, U.; Bastüzel Eyileten, Z.; Tunctan, B.; Sirlak, M.; Arikbuka, M.; Tasoz, R.; Uysalel, A., Efficiency of L-arginine supplemented cardioplegia and L-arginine supplemented non-cardiopegic blood controlled reperfusion for myocardial protection. 52nd International Congress of the European Society for Cardiovascular Surgery, 2003-11-07, 2003-11-10, İstanbul, Turkey, 2003. 27

10. Kiziltepe, U.; Bastuzel Eyileten, Z.; Tunctan, B.; Sirlak, M.; Emiroglu, O.; Tasoz, R.; Uysalel, A., Changes on systemic and cardiac nitric oxide production during open heart surgery. 52nd International Congress of the European Society for Cardiovascular Surgery, 2003-11-07, 2003-11-10, İstanbul, Turkey, 2003. 27

9. Tunctan, B.; Ozveren, E.; Korkmaz, B.; Buharalioglu, C.; Tamer, L.; Atik, U., Role of NFk-B and nitric oxide synthase in endotoxin-induced inflammatory hyperalgesi. 17th National Congress of Pharmacology, 1st Clinical Pharmacology Symposium & Joint Meeting of the Turkish & Dutch Pharmacological Societies, 2003-10-17, 2003-10-21, Antalya, Turkey, 2003. 42

8. Tunctan, B.; Yaghini, F.; Estes, A.; Malik, K., Inhibition by nitric oxide of cytochrome P450 4A expression and activity contributes to endotoxin-induced hypotension in rats. 17th National Congress of Pharmacology, 1st Clinical Pharmacology Symposium & Joint Meeting of the Turkish & Dutch Pharmacological Societies, 2003-10-17, 2003-10-21, Antalya, Turkey, 2003. 47

7. Eksioglu, U.; Tunctan, B.; Yalvac, I.; Babul, A.; Midillioglu, I.; Duman, S., Elevated aqueous humor nitric oxide levels differ in patients with different types of glaucoma. 4th International Glaucoma Symposium, 2003-03-19, 2003-03-22, Barcelona, Spain, 2003. 37

6. Gunaydin, B.; Sancak, B.; Candan, S.; Sariahmetoglu, M.; Ozcagli, G.; Tunctan, B.; Cakici, I., Temporal variation of oxidant stress in critically ill patients versus healthy subjects: Preliminary results. 25th Conference of International Society for Chronobiology, 2001-10-09, 2001-10-13, Antalya, Turkey, 2001. 12

5. Tunctan, B.; Altug, S.; Uludag, O.; Abacioglu, N., Day-night variations in nitric oxide production and mortality-induced by lipopolysaccharide in mice. The 4th Congress of Toxicology in Developing Countries, 1999-11-06, 1999-11-10, Antalya, Turkey, 1999. 47

4. Altug, S.; Uludag, O.; Tunctan, B.; Cakici, I.; Zengil, H.; Abacioglu, N., The bizarre chrononociceptive pattern of peroxynitrite. Second International Meeting on Pharmacy and Pharmaceutical Sciences, 1998-09-06, 1998-09-09, İstanbul, Turkey, 1998. 32

3. Uludag, O.; Tunctan, B.; Altug, S.; Zengil, H.; Abacioglu, N., Chemically-induced algesia in mice: L-arginine/NO/cGMP cascade and the rhythmicity of nitrite levels. International Conference. Nitric Oxide: Peripheral and Central Action, 1998-05-22, 1998-05-26, Antalya, Turkey, 1998. 40

2. Uludag, O., Chemically-induced algesia in mice: is there a nociceptive rhythmic pattern in L-arginine/NO/cGMP cascade?. International Conference. Nitric Oxide: Peripheral and Central Action, 1998-05-22, 1998-05-26, Antalya, Turkey, 1998. 0

1. Ozmen, M.; Col, C.; Cinel, I.; Isman, F.; Cinel, L.; Tunctan, B.; Berberoğlu, M., The correlation between reactive O2 species and histopathology of abdominal organs under increased insufflation pressure. Joint Euro-Asian Congress of Endoscopic Surgery, 1997-06-17, 1997-06-21, İstanbul, Turkey, 1997. 15

National - Full text - Poster 42

1. TUNÇTAN, B.; KÜÇÜKKAVRUK, Ş.; TEMİZ REŞİTOĞLU, M.; GÜDEN, D.; SARI, A.; FIRAT, S., Sıçanlarda oluşturulan deneysel septik şok modelinde seçici bir RXRa agonisti olan beksaroten enflamasyon ve doku zedelenmesi ile birlikte olan hipotansiyonu geri çevirmektedir. . 24. Ulusal Farmakoloji Kongresi, 2017-10-17, 2017-10-20, Trabzon, Turkey, 2017. 42
http://www.farmakoloji2017.org/

National - Abstract - Oral 437

17. Şenol, Ş.; Temiz, M.; Güden, D.; Çeçen, P.; Sarı, A.; Şahan Fırat, S.; Falck, J., Sıçanlarda oluşturulan deneysel septik şok modelinde 20-HETE mimetik 5,14-HEDGE'nin hipotansiyon, taşikardi ve enflamasyona karşı koruyucu etkisine PPARα/β/γ, AP-1, importin-α3 ve RXRα'nın katkısı. 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 5

16. Temiz, M.; Şenol, Ş.; Güden, D.; Çeçen, P.; Sarı, A.; Tunçtan, B.; Gorur, A., Endotoksemik sıçanlarda ortaya çıkan sistemik inflamatuvar yanıtta mTOR/IκB-α/NF-κB yolu etkinliğinin rolü. 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 7

15. Tunçtan, B., Çocuklarda ilaç kullanımı. 12. Türkiye Eczacılık Kongresi, 2014-09-25, 2014-09-27, Ankara, Turkey, 2014. 50

14. Sarı, A.; Korkmaz, B.; Serin, M.; Kaçan, M.; Ünsal, D.; Buharalıoğlu, C.; Şahan Fırat, S., Sıçanlarda oluşturulan deneysel septik şok modelinde 20-HETE analoğu 5,14-HEDGE'nin yararlı etkilerine MyD88/TAK1/IKKβ/NF-B yolu etkinliği ile birlikte sistemik miR-150, miR-223 ve miR-297 ekspresyon düzeylerindeki azalmanın katkısı. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 5

13. Kaçan, M.; Ünsal, D.; Temiz, M.; Korkmaz, B.; Sarı, A.; Şahan Fırat, S.; Yıldırım Yaroğlu, H., Sıçanlarda lipopolisakkarit ile oluşan enflamasyon ve hipotansiyona dalak tirozin kinazının katkısının araştırılması. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 5

12. Tunçtan, B., Septik şoklu hastalarda çoklu organ yetmezliği ve mortalitenin önlenmesi açısından tedavi yaklaşımları: Nitrik oksit sentaz inhibitörleri mi? Nitrik oksit vericileri mi? Nitrik oksit mi?. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 50

11. Urhan Küçük, M.; Sucu, N.; Şahan Fırat, S.; Aytaçoğlu, B.; Vezir, Ö.; Bozali, C.; Canacankatan, N., Ramiprilin koroner arter by pass cerrahisi hastalarında inflamatuar yanıt ve miyokardiyal hasara etkisinde ACE I/D gen polimorfizminin rolü. XIII. Ulusal Tıbbi Biyoloji ve Genetik Kongresi, 2013-10-27, 2013-10-30, Aydın, Turkey, 2013. 5

10. Tunçtan, B.; Korkmaz, B.; Cüez, T.; Sarı, A.; Kaçan, M.; Gilik, D.; Buharalıoğlu, C., Sıçan ve farelerde oluşturulan deneysel septik şok modelinde 20-HETE analoğu 5,14-HEDGE'nin hipotansiyonu ve mortaliteyi önleyici etkisine iNOS, COX-2, CYP4A1 ve NADPH oksidazın katkısı. XXI. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 32

9. Sarı, A.; Kaçan, M.; Gilik, D.; Şahan Fırat, S.; Buharalıoğlu, C.; Vezir, Ö.; Korkmaz, B., Sıçanlarda oluşturulan periferik iskemi/reperfüzyona bağlı hedef organ gastroknemius kası ve uzak organ böbrek zedelenmesine RhoA/Rho-kinaz/ERK1/2/iNOS/NADPH oksidaz yolunun katkısı. XXI. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 5

8. Korkmaz, B.; Cüez, T.; Buharalıoğlu, C.; Demiryürek, A.; Şahan Fırat, S.; Sarı, A.; Tunçtan, B., Endotoksemik sıçanlarda gelişen kaspaz-3 aracılıklı apoptoza ve oksidatif strese MEK1/ERK1/2/iNOS yolunun katkısı. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 10

7. Tunçtan, B.; Cüez, T.; Korkmaz, B.; Şahan Fırat, S.; Buharalıoğlu, C.; Yıldırım, H.; Sarı, A., Endotoksemik sıçanlarda NO oluşumundaki artmaya 20-HETE düzeylerindeki azalmanın eşlik ettiği oksidatif stres ve inflamasyon üzerinde yapay bir 20-HETE analoğu olan N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin etkisi. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 32

6. Korkmaz, B.; Buharalıoğlu, K.; Demiryürek, A.; Şahan Fırat, S.; Tunçtan, B., Endotoksemik sıçanların torasik aortasında gelişen vasküler hiporeaktiviteye indüklenebilir nitrik oksit sentaz/çözünebilir guanilil siklaz/protein kinaz G yolunun katkısı. IX. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 25

5. Tunçtan, B.; Korkmaz, B.; Buharalıoğlu, K.; Şahan Fırat, S.; Anjaiah, S.; Falck, J.; Roman, R., Endotoksin ile oluşan nitrik oksit aracılıklı hipotansiyon ve vasküler hiporeaktivite üzerinde selektif 20-hidroksieikozatetraenoik asit agonisti N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin etkileri. IX. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 37

4. Tunçtan, B.; Özveren, E.; Korkmaz, B.; Buharalıoğlu, C.; Tamer, L.; Değirmenci, U.; Değirmenci, U., Endotoksin ile oluşan nitrik oksit aracılıklı inflamatuvar hiperaljezide nükleer transkripsiyon faktörü k B, siklooksijenaz ve poli-ADP-riboz sentazın rolü. XVIII. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 40

3. Korkmaz, B.; Özveren, E.; Buharalıoğlu, C.; Tunçtan, B., Sıçan torasik aortunda endotoksin ile oluşan nitrik oksit ve prostaglandin aracılıklı hiporeaktiviteye mitojen ile aktive edilen protein kinaz sinyal ileti yolu katkıda bulunur. XVIII. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 32

2. Tunçtan, B.; Altuğ, S.; Uludağ, U.; Demirkay, B.; Abacıoğlu, N., Endotoksin ile farede oluşturulan septik şok modelinde mortalite, serum nitrit düzeyleri ve doku nitrik oksit sentaz aktivitesi üzerine siklooksijenaz inhibitörlerinin etkisi. XVI. Ulusal Farmakoloji Kongresi, 2001-10-01, 2001-10-05, İzmir, Turkey, 2001. 45

1. Tunçtan, B.; Demirkay, B.; Okur, H., Fare kan, böbrek, kalp ve akciğer kültüründe indüklenebilir nitrik oksit sentaz aktivitesi üzerinde guanilil siklaz, siklooksijenaz ve poliADP-riboz sentazın rolü. XVI. Ulusal Farmakoloji Kongresi, 2001-10-01, 2001-10-05, İzmir, Turkey, 2001. 50

National - Abstract - Poster 678

45. Cevher, F.; Ünal, S.; Küçükkavruk, Ş.; Taşdelen, B.; Tunçtan, B., Hidroksiüre tedavisi alan orak hücre hastalığı olan pediatrik ve genç erişkin hastalarda yaşam kalitesi, klinik etkinlik ve tedaviden memnuniyetin değerlendirilmesi. 24. Ulusal Farmakoloji Kongresi, 2017-10-17, 2017-10-20, Trabzon, Turkey, 2017. 12
http://www.farmakoloji2017.org/

44. Ünsal, D.; Kaçan, M.; Temiz, M.; Güden, D.; Korkmaz, B.; Sarı, A.; Buharalıoğlu, C., Sıçanlarda Dtk/IκB-α/NF-κB yolu etkinliğindeki artışın zimosanın neden olduğu inflamatuvar yanıta katkısı. 23. Ulusal Farmakoloji Kongresi, 2015-09-07, 2015-09-10, Ankara, Turkey, 2015. 2

43. Şenol, P.; Tiftik, N.; Ünal, S.; Akdeniz, A.; Taşdelen, B.; Tunçtan, B., Beta talasemi majör ve orak hücreli anemi hastalarında demir şelatörlerine uyuncun karşılaştırılması. 1. Talasemi ve Hemoglobinopatiler Kongresi, 2014-11-20, 2014-11-23, İzmir, Turkey, 2014. 10

42. Ordu, H.; Temiz, T.; Tunçtan, B.; Şahan-Fırat, S., Sağlığın sembolü: Gılgamış Destanı'ndan Asklepios'a yılan. XI. Türk Eczacılık Tarihi Toplantısı, 2014-05-25, 2014-05-28, Kayseri, Turkey, 2014. 18

41. Ünsal, D.; Kaçan, M.; Temiz, M.; Korkmaz, B.; Sarı, A.; Buharalıoğlu, C.; Yıldırım Yaroğlu, H., Sıçanlarda zimosanın neden olduğu enflamasyon ve hipotansiyona dalak tirozin kinazının katkısı. XXII. Ulusal Farmakoloji Kongresi, 2013-11-04, 2013-11-07, Antalya, Turkey, 2013. 2

40. Serin, M.; Tiftik, N.; Karakaya, B.; Tunçtan, B.; Döğen, A.; Tezcan, S.; Kaplan, E., Dengue virusunun (DENV) venöz tromboembolizmde yeri olan ADAMTS13 eksikliğindeki olası rolünün araştırılması. 7. Tanısal ve Moleküler Mikrobiyoloji Kongresi, 2012-06-05, 2012-06-08, Ankara, Turkey, 2012. 8

39. Görür, A.; Canacankatan, N.; Gül, E.; Algül, Ö.; Erdoğan, E.; Korkmaz, B.; Şahan-Fırat, S., Hepatoselüler karsinom gelişim sürecinde bazı benzimidazol türevlerinin antioksidan kapasite üzerine etkisi. 23. Ulusal Biyokimya Kongresi, 2011-11-29, 2011-12-02, Adana, Turkey, 2011. 2

38. Buharalıoğlu, C.; Sarı, A.; Kaçan, M.; Gilik, D.; Korkmaz, B.; Cüez, T.; Şahan Fırat, S., Endotoksemik sıçanlarda piroksikamın hipotansiyonu önleyici etkisine MEK1/ERK1/2/iNOS/NADPH oksidaz yolunun katkısı. XXI. Ulusal Farmakoloji Kongresi, 2011-10-19, 2011-10-22, Eskişehir, Turkey, 2011. 2

37. Cüez, T.; Korkmaz, B.; Buharalıoğlu, C.; Şahan Fırat, S.; Falck, J.; Malik, K.; Tunçtan, B., Endotoksemik sıçanlarda N-[20-hidroksieikoza-5(Z),14(Z)-dienoil]glisinin eNOS, iNOS ve hsp90 protein ekspresyonu ile prostanoit ve 20-HETE düzeyleri üzerindeki etkisi. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 5

36. Sarı, A.; Şahan Fırat, S.; Vezir, Ö.; Yılmaz, Ş.; Korkmaz, B.; Cüez, T.; Canacankatan, N., Seçici Rho-kinaz inhibitörü Y-27632'nin sıçanlarda oluşturulan periferik iskemi/reperfüzyona bağlı hedef organ gastroknemius kası ve uzak organ böbrek zedelenmesi üzerindeki etkisi. XX. Ulusal Farmakoloji Kongresi, 2009-11-04, 2009-11-07, Antalya, Turkey, 2009. 2

35. Sahan Fırat, S.; Canacankatan, N.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Buharalıoğlu, K.; Tunçtan, B., Endotoksemik sıçanların karaciğerinde artan oksidatif stres üzerinde indüklenebilir nitrik oksit sentaz inhibisyonunun etkisi. IX. Ulusal Farmakoloji Kongresi, 2007-10-24, 2007-10-27, Trabzon, Turkey, 2007. 5

34. Buharalıoğlu, C.; Korkmaz, B.; Yıldırım, H.; Tamer, L.; Atik, U.; Tunçtan, B., Nitrik oksidin böbrek sitozolik fosfolipaz A2 aktivitesini azaltıcı etkisi endotoksin ile oluşan hipotansiyona katkıda bulunabilir. XVIII. Ulusal Farmakoloji Kongresi, 2005-09-28, 2005-10-01, İzmir, Turkey, 2005. 10

33. Apçin, Y.; Savur, H.; Soytoprak, S.; Buharalıoğlu, C.; Tunçtan, B., Günümüzde klinik eczacı ve klinik eczacılık. II. Ulusal Eczacılık Öğrenci Kongresi, 2004-10-03, 2004-11-04, Mersin, Turkey, 2004. 12

32. Bayhan, A.; Menemenci, M.; Sivri, B.; Taş, E.; Buharalıoğlu, C.; Tunçtan, B., Akılcı ilaç kullanımında eczacının rolü. II. Ulusal Eczacılık Öğrenci Kongresi, 2004-10-03, 2004-10-04, Mersin, Turkey, 2004. 10

31. Yeni, G.; Bal, E.; Palangalı, E.; Buharalıoğlu, C.; Tunçtan, B., Yeni bin yılda ilaç sanayi ve eczacı. I. Ulusal Eczacılık Öğrenci Kongresi, 2003-10-03, 2003-10-04, Mersin, Turkey, 2003. 12

30. Buharalıoğlu, C.; Yüksel, A.; Şahin, N.; Yalın, S.; Tunçtan, B., ATC (Anatomical Therapeutic Chemical) ilaç sınıflandırma sistemi ve akılcı ilaç kullanımındaki rolü. VII. Türkiye Eczacılık Kongresi, 2003-06-19, 2003-06-21, İstanbul, Turkey, 2003. 12

29. Yalın, S.; Şahin, N.; Yüksel, A.; Buharalıoğlu, C.; Tunçtan, B., Günümüzde klinik eczacı ve klinik eczacılık. VII. Türkiye Eczacılık Kongresi, 2003-06-19, 2003-06-21, İstanbul, Turkey, 2003. 12

28. Şahin, N.; Yalın, S.; Yüksel, A.; Buharalıoğlu, C.; Tunçtan, B., 21. Yüzyılda hastalıkların tedavisinde yeni bir yaklaşım: Gen tedavisi ve farmakogenomik. VII. Türkiye Eczacılık Kongresi, 2003-06-19, 2003-06-21, İstanbul, Turkey, 2003. 12

27. Şahan, L.; Günal, H.; Göktaş, U.; Leblebici, F.; Şavkılıoğlu, E.; Tunçtan, B., Kombine ve genel anestezinin hemodinami, oksijenizasyon ve nitrik oksit (NO) üzerine etkileri. Türk Anesteziyoloji ve Reanimasyon Derneği XXXV. Kongresi, 2001-10-27, 2001-10-31, Antalya, Turkey, 2001. 10

26. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N., Septik şok tedavisinde ekonazol yararlı olabilir mi? . XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 23

25. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N., Günün farklı saatlerinde lipopolisakkarit uygulanmasının fare serum nitrit, 6-k-PGF1a ve TxB2 düzeylerinde oluşturduğu güniçi değişiklikler. XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 23

24. Soyak, G.; Hoşgör, B.; Ademoğlu, F.; Tunçtan, B.; Çakıcı, İ.; Abacıoğlu, N., Melatoninin kronosisepsiyondaki etkileri. XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 13

23. Tunçtan, B.; Altuğ, S.; Uludağ, O.; Abacıoğlu, N., Lipopolisakkarit ile farede oluşturulan septik şok modelinde indometazinin oluşturduğu serum nitrit düzeyleri ve mortaliteye pentoksifilinin etkisi. XV. Ulusal Farmakoloji Kongresi, 1999-11-01, 1999-11-05, Antalya, Turkey, 1999. 23

22. Tunctan, B.; Uludag, O.; Altug, S.; Abacioglu, N., Is nitric oxide synthase inhibition beneficial in lipopolysaccharide-induced sepsis in mice?. International Conference. Nitric Oxide: Peripheral and Central Actions, 1998-05-22, 1998-05-26, Antalya, Turkey, 1998. 23

21. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., p-Benzokinon ile oluşturulan abdominal konstriksiyon modelinde mepiraminin etkileri ve serum nitrit düzeylerinin kronoritmisitesi (I). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

20. Tunçtan, B.; Uludağ, O.; Çalışır, C.; Abacıoğlu, H.; Çakıcı, İ.; Kanzık, İ.; Abacıoğlu, N., Aktif pulmoner tüberkülozlu hastaların serum nitrit ve TNFa düzeyleri üzerine antitüberküloz tedavinin etkisi. XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

19. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Sodyum nitroprusid ile indüklenen antinosiseptif aktivite ve serum nitrit düzeylerinin sirkadiyan ritmisitesi (IV). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

18. Abacıoğlu, N.; Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H., p-Benzokinon ile oluşturulan abdominal konstriksiyon modelinde L-arjinin etkileri ve serum nitrit düzeylerinin kronoritmisitesi (II). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 17

17. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Guanilil siklaz inhibisyonunun mepiramin kronoantinosisepsiyonunda ve serum nitrit düzeyleri üzerine etkisi (IX). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

16. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., L-arjinin ve mepiramin etkileşmesiyle indüklenen nosiseptif proseslerde gözlenen güniçi değişiklikler (VI). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

15. Uludağ, O.; Altuğ, S.; Tunçtan, B.; Zengil, H.; Abacıoğlu, N., L-arjinin/nitrik oksit kaskadında rolü olan ajanların fare serum nitrit düzeylerinin pik ve çukur değerlerin kronoritmisitesi bakımından mepiramin ile etkileşmesi (X). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 17

14. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Sodyum nitroprusid ve mepiramin ile indüklenen antinosiseptif aktivite ve serum nitrit düzeylerinin kronoritmisite kalıbı (VIII). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

13. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., p-BK ile oluşturulan abdominal konstriksiyon modelinde metilen mavisinin etkileri ve serum nitrit düzeylerinin kronoritmisitesi (V). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

12. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., p-Benzokinon ile oluşturulan abdominal konstriksiyon modelinde L-NAME’in etkileri ve serum nitrit düzeylerinin kronoritmisitesi (III). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

11. Tunçtan, B.; Uludağ, O.; Altuğ, S.; Abacıoğlu, N., iNOS ve COX-2 inhibisyonunun LPS ile farede oluşturulan septik şok modelindeki rolü. XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 23

10. Uludağ, O.; Tunçtan, B.; Altuğ, S.; Zengil, H.; Abacıoğlu, N., Mepiramin ve L-NAME etkileşmesiyle indüklenen antinosiseptif aktivitenin ve serum nitrit düzeylerinin kronoritmisite kalıbı (VII). XIV. Ulusal Farmakoloji Kongresi, 1997-11-02, 1997-11-07, Antalya, Turkey, 1997. 20

9. Abacıoğlu, N.; Uludağ, O.; Tunçtan, B.; Güney, H.; Zengil, H., Nosisepsiyonda L-arjininin doza bağımlı trifazik etkisi ve 1. fazın kronoritmisitesi. 2. Ulusal Toksikoloji Kongresi, 1997-04-03, 1997-04-06, Antalya, Turkey, 1997. 17

8. Uludağ, O.; Tunçtan, B.; Zengil, H.; Abacıoğlu, N., Farelerde güniçi serum nitrit düzeylerinin p-benzokinon (p-BK) ile değişiminin incelenmesi. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 21

7. Akbulut, E.; Tunçtan, B.; Uludağ, O.; Çakıcı, İ.; Kanzık, İ.; Abacıoğlu, N., Piridoksinin antinosiseptif etkisinde nitrik oksidin rolü. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 18

6. Tunçtan, B.; Okur, H.; Çalışır, C.; Abacıoğlu, H.; Çakıcı, İ.; Kanzık, İ.; Abacıoğlu, N., Sağlıklı ve aktif pulmoner tüberkülozlu bireylerin monosit/makrofajlarında nitrik oksit oluşumunun diazotizasyon ve biyoesey yöntemleri ile karşılaştırılması. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1196. 20

5. Güney, H.; Görgün, C.; Tunçtan, B.; Uludağ, O.; Hodoğlugil, U.; Abacıoğlu, N.; Zengil, H., L-nitroarginin metil ester (L-NAME), morfin analjezisini zaman bağımlı olarak etkiliyor. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 15

4. Güney, H.; Tunçtan, B.; Uluoğlu, C.; Uludağ, O.; Abacıoğlu, N.; Zengil, H., Sıçanlarda serum nitrit düzeylerindeki zaman bağımlı değişikliklerin incelenmesi. XIII. Ulusal Farmakoloji Kongresi, 1996-11-05, 1996-11-08, Antalya, Turkey, 1996. 18

3. Tunçtan, B.; Abacıoğlu, N.; Özmen, R.; Çakıcı, İ.; Kanzık, İ.; Demiryürek, A., Farede mepiramin ve morfinin oluşturduğu antinosiseptif aktiviteye L-arjinin ve NG-monometil-L-arjininin katkısı. XII. Ulusal Farmakoloji Kongresi, 1994-10-31, 1994-11-04, Antalya, Turkey, 1994. 21

2. Akbulut, E.; Abacıoğlu, N.; Demir, S.; Çakıcı, İ.; Tunçtan, B.; Kanzık, İ.; Demiryürek, A., Farede tiamin ve morfinin oluşturduğu antinosiseptif aktiviteye L-arjinin/NO-sGMP yolağının katkısı. XII. Ulusal Farmakoloji Kongresi, 1994-10-31, 1994-11-04, Antalya, Turkey, 1994. 10

1. Tunçtan, B.; Çakıcı, İ.; Abacıoğlu, N.; Kanzık, I., Bazı agonistlerin etkileri üzerinde solunum yolu epitelinin rolü. XI. Ulusal Farmakoloji Kongresi, 1992-11-04, 1992-11-08, Nevşehir, Turkey, 1992. 23

National - Manager 2800

31. Investigation of the effect of 20-HETE mimetic 5,14-HEDGE on GPR75/Gaq/11 signalling pathway in lipopolysaccharide-induced systemic inflammation model in rats, BAP, Project Number: 2019-1-AP3-3471, 23000 TL, Manager, Continue... 100

30. Investigation of the effect of soluble epoxide hydrolase inhibition in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, BAP, Project Number: 2018-3-TP2-3082, 11000 TL, Manager, Continue... 100

29. Investigation of the effect of soluble epoxide hydrolase inhibition in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in experimental autoimmune encephalomyelitis model in mice, BAP, Project Number: 2019-1-TP2-3142, 9936 TL, Manager, Continue... 100

28. Investigation of the effect of selective RXRα agonist, bexarotene, on TLR4/MyD88/TAK1/NF-κB/COX-2 pathway in relation to proinflammatory cytokine production in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, BAP, Project Number: 2018-1-TP3-2814, 21000 TL, Manager, 2020, Continue... 100

27. Lipopolisakkarit ile farelerde oluşturulan inflamatuvar hiperaljezi modelinde seçici RXRα agonisti beksarotenin TLR4/MyD88/TAK1/NF-κB/COX-2 yolu üzerindeki etkisinin proinflamatuvar sitokin oluşumu ile ilişkilendirilerek araştırılması , TÜBİTAK, Project Number: 217S235, 30000 TL, Manager, 2019,Completed. 100

26. Investigation of the effect of selective RXRα agonist, bexarotene, on iNOS and CYP4F6 expression and activity in lipopolysaccharide-induced systemic inflammation model, TÜBİTAK, Project Number: 215S679, 220000 TL, Manager, 2018,Completed. 100

25. Investigation of the effect of 20-HETE mimetic, 5,14-HEDGE, on NLRP3/ASC/pro-caspase-1 inflammasome formation and activity in lipopolysaccharide-induced septic shock model in rats, BAP, Project Number: 2015-AP3-1343, 20000 TL, Manager, 2017,Completed. 100

24. Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, TÜBİTAK, Project Number: 215S047, 30000 TL, Manager, 2016,Completed. 100

23. Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, BAP, Project Number: 2016-1-TP2-1427, 11000 TL, Manager, 2016,Completed. 100

22. Investigation of the effect of 20-HETE agonist, 5,14-HEDGE, on PPARa/β/g, c-jun, importin-a3, and RXRa expression in renal and cardiovascular tissues of endotoxemic rats, BAP, Project Number: BAP-SBE FB (ŞPŞ) 2014-3 YL, 10000 TL, Manager, 2015,Completed. 100

21. Investigation of the effect of 20-HETE agonist, 5,14-HEDGE, on systemic miR-150, miR-223, and miR-297 levels in relation with activity of MyD88/TAK1/NF-kB pathway in endotoxemic rats, BAP, Project Number: BAP-SBE EMBB (ANS) 2012-4 DR, 20000 TL, Manager, 2013,Completed. 100

20. Determination of bisphenol-A level in the people in Mersin, BAP, Project Number: BAP-SBE FT (DB) 2011-7 YL, 10000 TL, Manager, 2012,Completed. 100

19. Investigation of the effect of a satble 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity , BAP, Project Number: BAP-ECZ F EMBB (BT) 2012-4 HD, 590 TL, Manager, 2012,Completed. 100

18. Investigation of the effect of a 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity in relation with proinflammatory cytokine production and MEK1/ERK1/2/NF-kB pathway in endotoxemic , BAP, Project Number: BAP-ECZ F FB (BT) 2010-5 B, 42000 TL, Manager, 2012,Completed. 100

17. Investigation of molecular mechanism of the interaction between nitric oxide synthase, cyclooxygenase and cytochrome P450 4A enzymes in cardiac, renal and vascular tissues of endotoxemic rats, TÜBİTAK, Project Number: 109S121, 280000 TL, Manager, 2012,Completed. 100

16. Contribution of COX-2 products to hypotension associated with increased NO production and decreased 20-HETE levels in endotoxemic rats, Novartis, Project Number: ---, 13000 TL, Manager, 2012,Completed. 0

15. Investigation of the effect of a stable 20-HETE analogue, 5,14-HEDGE, on CYP2C23-dependent renal epoxygenase and soluble epoxide hydrolase expression and activity , BAP, Project Number: BAP-ECZ F MBB (BT) 2010-5 HD, 958 TL, Manager, 2011,Completed. 100

14. Investigation of the mechanism of preventive effect of selective 20-HETE agonist N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine on endotoxin-induced hypotension, BAP, Project Number: BAP SBE EMB (TC) 2008-6 DR, 10000 TL, Manager, 2010,Completed. 100

13. Effect of selective Rho-kinase inhibitor, Y-27632, on ischemia/reperfusion-induced target-organ skeletal muscle and end-organ kidney damage, BAP, Project Number: BAP SBE EMB (ANS) 2008-9 YL, 7847 TL, Manager, 2009,Completed. 100

12. Investigation of the preventive effect of selective 20-HETE agonist N-[20-hydroxyeicosa-5(Z),14(Z)-dienoyl]glycine on endotoxin-induced and nitric oxide-mediated hypotension and vascular hyporeactivity, Novartis, Project Number: ---, 10000 TL, Manager, 2009,Completed. 0

11. Investigation of the mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 and inducible nitric oxide pathway in endotoxemic rats, TÜBİTAK, Project Number: 106S299, 70584 TL, Manager, 2009,Completed. 100

10. Investigation of the mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 pathway in endotoxemic rats, BAP, Project Number: BAP SBE EMB (RBK) 2006-3 DR, 6000 TL, Manager, 2008,Completed. 100

9. Investigation of the effects of thalidomide in endotoxin-induced hyperalgesia, BAP, Project Number: BAP SBE EMB (OO) 2006-3 YL, 6000 TL, Manager, 2008,Completed. 100

8. Contribution of cytochrom P450 and cyclooxygenase products endotoxin-induced and nitric oxide-mediated hypotension, BAP, Project Number: BAP ECZF EMB (BT) 2006-3, 10000 TL, Manager, 2008,Completed. 100

7. Investigation of the importance of mitogen-activated extracellular signal regulated kinase (ERK1/2) pathway in endotoxin-induced and nitric oxide-mediated hypotension, BAP, Project Number: BAP ECZF EMB (BT) 2004-3, 21397 TL, Manager, 2006,Completed. 100

6. The investigation of the mechanisms of relationship among g protein-coupled alpha-adrenergic receptor/mitogen-activated kinases pathway, cytosolic phospholipase A2 and inducible nitric oxide synthase enzymes in endotoxin induced vascular hyporeactivity, BAP, Project Number: BAP SBE EMB (RBK) 2003-1 YL, 1900 TL, Manager, 2004,Completed. 100

5. Investigation of G protein-coupled receptor related changes induced by endotoxin in rat mesenteric artery, BAP, Project Number: BAP SBE EMB (EO) 2003-1 YL, 2000 TL, Manager, 2004,Completed. 100

4. Investigation of G protein-coupled receptor related changes induced by endotoxin in rat mesenteric artery, BAP, Project Number: BAP ECZ FMB (BT) 2002, 35000 TL, Manager, 2004,Completed. 100

3. Role of NF-kB, nitric oxide synthase, cyclooxygenase and poli ADP-ribose synthase in endotoxin-induced inflammatory hyperalgesia, Novartis, Project Number: ---, 3500 TL, Manager, 2004,Completed. 0

2. Role of tyrosine kinase, guanylyl cyclase, cyclooxygenase and polyADP-riboz sentaz on inducible nitric oxide synthase activity in kidney, heart and lung culture in mice, BAP, Project Number: EF-02/2001-01, 0 TL, Manager, 2001,Completed. 100

1. The role of inhibition of iNOS and COX-2 in septic shock, BAP, Project Number: EF-02/98-06, 0 TL, Manager, 1999,Completed. 100

National - Researcher 550

12. Investigation of the involvement of mTOR on DOCA-salt-induced hypertension and related cardiovascular and renal pathophysiological changes in rats, TÜBİTAK, Project Number: 118S168, 15500 TL, Researcher, Continue... 50

11. Investigation of the Role of mTOR in Systemic Inflammatory Response in Zymosan-Induced Non-Septic Shock Model in Rats, BAP, Project Number: 2016-2-AP3-1900, 14450 TL, Researcher, 2017,Completed. 50

10. Investigation of the effect of Dtk inhibition on NF-kB signal transduction pathway in septic and nonseptic shock models, BAP, Project Number: BAP-ECZ F EMBF (SŞF) 2012-6 B, 56134 TL, Researcher, 2015,Completed. 50

9. Determination of some endocrine disruptors (bisphenol A (BPA), 4-t-octilphenol (4-t-OP) ve 4-nonilphenol (4-NP)) in human urine samples using liquid chromatography-mass spectrometry (LC/MS/MS) method, BAP, Project Number: BAP-ECZ F EMBB (DB) 2012-8 A, 24996 TL, Researcher, 2015,Completed. 50

8. Investigation of the possible role of some tropical viral and parasiter agents on the stimulation of inhibitor autoantibodies-induced ADAMTS-13 deficiency, BAP, Project Number: BAP-ECZ F TEB (MSS) 2010-3 A, 23996 TL, Researcher, 2014,Completed. 50

7. Mersin Chamber of Industry and Commerce (Project Partner). University-city cooperation action plan, Çukurova Kalkınma Ajansı, Project Number: TR62-12-DFD/004, 85284 TL, Researcher, 2013,Completed. 0

6. Investigation of the contribution of spleen tyrosine kinase to endotoxin-induced hypotension in rats, BAP, Project Number: BAP SBE F (MK) 2011-5 YL, 10000 TL, Researcher, 2012,Completed. 50

5. Investigation of the contribution of spleen tyrosine kinase to zymosan-induced hypotension in rats, BAP, Project Number: BAP SBE F (DG) 2011-5 YL, 10000 TL, Researcher, 2012,Completed. 50

4. Investigation of the relationship between ACE gene polymorphism and effect of ACE inhibition on myocardial injury during cardiopulmonary bypass, BAP, Project Number: BAP-TF CTB (NS) 2009-3, 17005 TL, Researcher, 2012,Completed. 50

3. Investigation of the relationship between IL-6, IL-8 and TNF-alpha gene polymorphism and myocardial injury during cardiopulmonary bypass in patients under ACE inhibitor therapy, BAP, Project Number: FEFBAP 2009-2, 4000 TL, Researcher, 2011,Completed. 50

2. Mechanism of apoptosis in hepatocellular carcinoma and effect of some benzimidazole derivatives on hepatocellular carcinoma, BAP, Project Number: BAP-SBE BA (AG) 2008-9 YL, 5969 TL, Researcher, 2009,Completed. 50

1. Investigation of the role and importance of pharmacological inhibition of cytosolic phospholipase A2 in sepsis pathogenesis, BAP, Project Number: BAP ECZ F EMB (KB) 2003-1, 17000 TL, Researcher, 2005,Completed. 50

National - Advisor 50

1. ---, TÜBİTAK, Project Number: 216S127, 0 TL, Advisor, Continue... 50

National - Advisor 0

2. Development and Preclinical Studies of New Drug Candidates Targeting PI3K/Akt Signaling Pathway for Treatment of Breast and Liver Cancer, TÜBİTAK, Project Number: 215S015, 0 TL, Advisor, 2019,Completed. 0

1. The comparison of the effectiveness of resveratrol and silibinin for preventing alpha amanitin-induced liver toxicity, TÜBİTAK, Project Number: 114S927, 0 TL, Advisor, 2016,Completed. 0

Supervised Master Theses 2200

11. Merve BİLİKTÜ, Investigation of the effect of inhibition of soluble epoxide hydrolase in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in experimental autoimmune encephalomyelitis model in mice, Graduate School of Health Sciences, Mersin University, Continue. 200

10. Ali CAĞLİ, Investigation of the effect of inhibition of soluble epoxide hydrolase in relation to NLRC4 inflammasome and antiinflammatory NLRC3 in lipopolysaccharide-induced inflammatory hyperalgesia model in mice, Graduate School of Health Sciences, Mersin University, Continue. 200

9. Furkan CEVHER, Evaluation of clinical effectiveness, quality of life, and satisfaction in patients with sickle cell anemia receiving hydroxyurea, Graduate School of Health Sciences, Mersin University, 2016, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

8. Abdurrahman DOLUNAY, Investigation of the contribution of NLRP3 inflammasome to lipopolysaccharide-induced inflammatory hyperalgesia in mice, Graduate School of Health Sciences, Mersin University, 2016, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

7. Şefika Pınar ŞENOL, Investigation of the Effect of 5,14-HEDGE, a 20-HETE Mimetic, on PPARα/β/γ, c-Jun, Importin-α3, and RXRα Expression in Renal and Cardiovascular Tissues of Endotoxemic Rats, Graduate School of Health Sciences, Mersin University, 2014, Completed. 200

6. Şefika Pınar ŞENOL, Comparison of Iron Chelators in Terms of Compliance to Treatment in Patients with Thalassemia and Sickle Cell Anemia, Graduate School of Health Sciences, Ankara University, 2014, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

5. Dilek BATTAL, Determination of bisphenol-A level in the people in Mersin, Graduate School of Health Sciences, Mersin University, 2012, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

4. A. Nihal SARI, Effect of Selective Rho-Kinase Inhibitor Y-27632 on End Organ Kidney and Target Organ Skeletal Muscle Depend on Peripheric Ischemia/Reperfusion Damage, Graduate School of Health Sciences, Mersin University, 2010, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

3. Orçun ÖZBAŞOĞLU, Investigation of the Effects of Thalidomide on Endotoxin-Induced Inflammatory Hyperalgesia, Graduate School of Health Sciences, Mersin University, 2009, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

2. R. Belma KORKMAZ, The Investigation of the Mechanisms of Relationship among G Protein-Coupled Alpha-Adrenergic Receptor/Mitogen-Activated Kinases Pathway, Cytosolic Phospholipase A2 and Inducible Nitric Oxide Synthase Enzymes in Endotoxin Induced Vascular ..., Graduate School of Health Sciences, Mersin University, 2004, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

1. Elif ÖZVEREN, Investigation of mechanisms of endotoxin-induced changes in G protein-related signalling pathway in rat mesenteric artery, Graduate School of Health Sciences, Mersin University, 2004, Completed. 200
https://tez.yok.gov.tr/UlusalTezMerkezi/

Supervised Doctorate Theses 1200

3. A. Nihal SARI, Investigation of the Effect of 20-HETE Analog, 5,14-HEDGE, on Systemic miR-150, miR-223, and miR-297 Levels in Relation with Activity of MyD88/TAK1/NF-kB Pathway in Endotoxemic Rats, Graduate School of Health Sciences, Mersin University, 2013, Completed. 400
https://tez.yok.gov.tr/UlusalTezMerkezi/

2. Tuba CÜEZ, Investigation of the Mechanism of Preventive Effect of 20-HETE Agonist N-[20-Hydroxyeicosa-5(Z),14(Z)-Dienoyl]Glycine on Endotoxin-Induced Hypotension, Graduate School of Health Sciences, Mersin University, 2010, Completed. 400
https://tez.yok.gov.tr/UlusalTezMerkezi/

1. R. Belma KORKMAZ, Investigation of mechanisms of vascular hyporeactivity mediated by extracellular signal-regulated kinase 1/2 and inducible nitric oxide synthase pathway in endotoxemic rats, Graduate School of Health Sciences, Mersin University, 2009, Completed. 400
https://tez.yok.gov.tr/UlusalTezMerkezi/

International 4250
1. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY , EDITOR, ISSN : 1875-614X, E-ISSN : 1871-5230, 2004-01-01 - 2015-12-31. 2000
2. ANTI-INFLAMMATORY & ANTI-ALLERGY AGENTS IN MEDICINAL CHEMISTRY , ASSOCIATE EDITOR, ISSN : 1875-614X, E-ISSN : 1871-5230, 2016-01-01 - Continue. 1000
3. AUSTIN JOURNAL OF PHARMACOLOGY & THERAPEUTICS , PUBLICATION BOARD MEMBER, E-ISSN : 2373-6208, 2014-05-22 - Continue. 250
4. INTERNATIONAL JOURNALS OF CANCER STUDIES & RESEARCH , PUBLICATION BOARD MEMBER, E-ISSN : 2167-9118, 2012-11-26 - Continue. 250
5. PROSTAGLANDINS AND OTHER LIPID MEDIATORS , PUBLICATION BOARD MEMBER, E-ISSN : 1098-8823, 2012-03-22 - Continue. 500
6. TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES - TURKIYE KLINIKLERI TIP BILIMLERI DERGISI , ADVISORY BOARD MEMBER, E-ISSN : 1300-0292, 2010-02-01 - Continue. 250
National 190
1. MERSIN UNIVERSITESI TIP FAKULTESI LOKMAN HEKIM TIP TARIHI VE FOLKLORIK TIP DERGISI , PUBLICATION BOARD MEMBER, ISSN : 1309–8004, 2010-07-21 - Continue. 125
2. TURKIYE KLINIKLERI ECZACILIK BILIMLERI DERGISI , ADVISORY BOARD MEMBER, E-ISSN : 2146-944X, 2010-10-22 - Continue. 65
International Journal [Year, Count] 717
1. TURKIYE KLINIKLERI JOURNAL OF MEDICAL SCIENCES - TüRKIYE KLINIKLERI TıP BILIMLERI DERGISI , [ 2010 : 9 ] . 45
2. ACS MEDICINAL CHEMISTRY LETTERS , [ 2016 : 1 ] . 5
3. AFRICAN JOURNAL OF INTERNAL MEDICINE , [ 2012 : 1 ] . 5
4. AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY , [ 2012 : 1 ] [ 2009 : 2 ] . 15
5. BIOLOGICAL RESEARCH FOR NURSING , [ 2008 : 1 ] . 5
6. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , [ 2015 : 1 ] . 5
7. CELL BIOLOGY INTERNATIONAL , [ 2006 : 1 ] . 5
8. CENTRAL EUROPEAN JOURNAL OF IMMUNOLOGY , [ 2015 : 1 ] [ 2016 : 1 ] . 10
9. CLINICAL SCIENCE , [ 2017 : 1 ] . 5
10. CLINICAL AND EXPERIMENTAL PATHOLOGY , [ 2013 : 1 ] . 5
11. CURRENT DRUG METABOLISM , [ 2013 : 1 ] [ 2012 : 1 ] . 10
12. CURRENT PHARMACEUTICAL DESIGN , [ 2017 : 1 ] . 5
13. EXPERIMENTAL AND THERAPEUTIC MEDICINE , [ 2017 : 1 ] . 5
14. INFLAMMATION RESEARCH , [ 2009 : 2 ] . 10
15. INNATE IMMUNITY , [ 2016 : 2 ] . 10
16. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES , [ 2017 : 2 ] . 10
17. INTERNATIONAL JOURNAL OF MEDICINE AND MEDICAL SCIENCES , [ 2009 : 2 ] . 10
18. INTERNATIONAL RESEARCH JOURNAL OF MICROBIOLOGY , [ 2010 : 1 ] . 4
19. JOURNAL OF APPLIED BIOPHARMACEUTICS AND PHARMACOKINETICS , [ 2014 : 1 ] [ 2013 : 3 ] . 16
20. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS , [ 2015 : 1 ] . 5
21. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE , [ 2018 : 1 ] . 5
22. JOURNAL OF ETHNOPHARMACOLOGY , [ 2014 : 1 ] [ 2012 : 7 ] [ 2011 : 13 ] [ 2010 : 16 ] [ 2009 : 6 ] [ 2008 : 2 ] [ 2007 : 11 ] [ 2006 : 1 ] . 285
23. JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY , [ 2017 : 2 ] . 10
24. JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY , [ 2015 : 2 ] [ 2013 : 2 ] [ 2016 : 1 ] . 25
25. JOURNAL OF PULMONARY & RESPIRATORY MEDICINE , [ 2013 : 1 ] . 4
26. LIFE SCIENCES , [ 2014 : 1 ] . 5
27. MARMARA PHARMACEUTICAL JOURNAL , [ 2016 : 1 ] . 4
28. METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY , [ 2007 : 1 ] . 5
29. MICROBIOLOGICAL PATHOGENESIS , [ 2018 : 1 ] . 4
30. MINI REVIEWS IN MEDICINAL CHEMISTRY , [ 2008 : 1 ] . 5
31. NITRIC OXIDE: BIOLOGY AND CHEMISTRY , [ 2015 : 3 ] [ 2014 : 1 ] [ 2013 : 3 ] [ 2012 : 4 ] [ 2007 : 1 ] [ 2006 : 3 ] [ 2005 : 1 ] . 80
32. PHARMACOLOGICAL RESEARCH , [ 2011 : 1 ] [ 2006 : 2 ] . 15
33. PROSTAGLANDINS AND OTHER LIPID MEDIATORS , [ 2015 : 2 ] [ 2014 : 2 ] [ 2013 : 1 ] [ 2011 : 1 ] [ 2016 : 2 ] [ 2017 : 1 ] . 45
34. THE ANATOLIAN JOURNAL OF CARDIOLOGY , [ 2015 : 1 ] . 5
35. TOXICOLOGY AND APPLIED PHARMACOLOGY , [ 2014 : 1 ] . 5
36. TURKISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY-TüRK GöğüS KALP DAMAR CERRAHISI DERGISI , [ 2015 : 2 ] [ 2013 : 1 ] [ 2016 : 1 ] . 20
37. VASCULAR PHARMACOLOGY , [ 2014 : 1 ] . 5
National Journal [Year, Count] 19
1. GAZI MEDICAL JOURNAL , [ 2008 : 1 ] . 1
2. HACETTEPE UNIVERSITESI ECZACILIK FAKULTESI DERGISI , [ 2009 : 1 ] . 1
3. KLINIK PSIKIYATRI DERGISI , [ 2007 : 1 ] . 1
4. MARMARA UNIVERSITESI SAGLIK BILIMLERI ENSTITUSU DERGISI , [ 2015 : 2 ] . 2
5. MERSIN UNIVERSITESI SAGLIK BILIMLERI DERGISI , [ 2014 : 2 ] [ 2013 : 1 ] [ 2012 : 1 ] [ 2010 : 2 ] [ 2008 : 1 ] . 7
6. TURKIYE KLINIKLERI ECZACILIK BILIMLERI DERGISI , [ 2013 : 1 ] [ 2012 : 2 ] [ 2011 : 3 ] [ 2017 : 1 ] . 7
International
1. , 2003-06-09 - 2003-10-09, Memphis, United States of America.
2. , 2002-05-01 - 2002-09-01, , Turkey.
3. , 1998-10-29 - 1999-01-29, Memphis, United States of America.
International 50
1. , 2012-09-19, Budapeşte, Hungary. 50
2. WORLD ACADEMY OF SCIENCE, ENGINEERING, AND TECHNOLOGY, 2017-05-14, Amsterdam, Netherlands. 0
National 100
1. , 2008-04-14, Ankara, Turkey. 50
2. , 2010-04-14, Ankara, Turkey. 50
3. Journal of Pharmacy, 2015-11-27, İstanbul, Turkey. 0
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 1-2-2
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 501 General Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 502 Drugs Affecting Autonomic Nervous System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 504 Drugs Affecting Renal System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 623 Inflammation and Antiinflammatory Drugs Institute of Health Sciences Pharmacy Pharmacology 1-0-1
Fall FMK 606 Pharmacology of Communication Between Au... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Fall ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ432 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 0-2-1
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 1-2-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ430 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 2-0-2
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring ILC202 Ilac Bilgisi II Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 1-2-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall FMK 504 Drugs Affecting Renal System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall SEM DR Seminar I Institute of Health Sciences Institute of Health Sciences 0-0-0
Fall FMK 608 Pharmacokinetics Institute of Health Sciences Pharmacy Pharmacology 3-0-3
Fall FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 501 General Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 502 Drugs Affecting Autonomic Nervous System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-3
Spring ECZ128 Introduction To Pharmacy Profession and ... Faculty of Pharmacy Pharmacy 4-0-4
Spring ECZ422 Pharmacy Law & Administration Faculty of Pharmacy Pharmacy 4-0-4
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 502 Drugs Affecting Autonomic Nervous System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 501 General Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring SEM DR Seminar II Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring FMK 506 Drugs Affecting Endocrine System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring ILC202 Ilac Bilgisi II Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ509 Hospital Pharmacy Practice Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 2-6-5
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 603 Mechanisms For Searching and Evaluation ... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 501 General Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 502 Drugs Affecting Autonomic Nervous System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 605 Pharmacology of Smooth Muscie and Skelet... Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Fall ILC201 Drug Information I Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Fall ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ430 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ432 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 0-3-1
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-2
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring FMK 601 Mechanisms For Drug Action Institute of Health Sciences Pharmacy Pharmacology 3-0-3
Spring FMK 607 Experimental Pharmacology II Institute of Health Sciences Pharmacy Pharmacology 2-4-4
Spring SEM DR Seminar I Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring ILC202 Ilac Bilgisi II Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-2
Fall ECZ513 Quality Assurance In Industrial Pharmacy Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ501 Graduation Research Project - I Faculty of Pharmacy Pharmacy 2-6-4
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ503 Management of Community Pharmacy Faculty of Pharmacy Pharmacy 2-0-2
Fall FMK 605 Pharmacology of Smooth Muscie and Skelet... Institute of Health Sciences Pharmacy Pharmacology 2-2-3
Fall FMK 603 Mechanisms For Searching and Evaluation ... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 501 General Pharmacology Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Fall FMK 502 Drugs Affecting Autonomic Nervous System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Fall ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Fall ILC201 Drug Information I Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ502 Graduation Research Project - II Faculty of Pharmacy Pharmacy 0-5-2
Spring FMK 515 Scientific Presentation and Writing Tech... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring SEM YL Seminar Institute of Health Sciences Institute of Health Sciences 0-0-0
Spring FMK 603 Mechanisms For Searching and Evaluation ... Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring FMK 506 Drugs Affecting Endocrine System Institute of Health Sciences Pharmacy Pharmacology 2-0-2
Spring FMK 801 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring FMK 802 Specialty Area Institute of Health Sciences Department of Pharmacy Pharmac... 4-0-4
Spring ILC202 Pharmaceutical Information II Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ441 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 0-3-1
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ505 Community Pharmacy Practice Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ439 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 2-0-2
Fall FMK 501 General Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 617 Professional Ethics Graduate School of Health Scie... PHARMACY PHARMACOLOGY 1-0-1
Fall FMK 610 Pharmacology of Communication Between Ho... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 504 Drugs Affecting Renal System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 506 Drugs Affecting Endocrine System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall ILC201 Drug Information I Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring FMK 601 Mechanisms For Drug Action Graduate School of Health Scie... PHARMACY PHARMACOLOGY 3-0-3
Spring FMK 504 Drugs Affecting Renal System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FMK 501 General Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FMK 602 Pharmacology Communication Between Neuro... Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring ILC202 Ilac Bilgisi II Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ503 Management of Community Pharmacy Faculty of Pharmacy Pharmacy 2-0-2
Fall FMK 512 Experimental Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Fall FMK 501 General Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring FMK 501 General Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring FMK 614 Seminar Graduate School of Health Scie... PHARMACY PHARMACOLOGY 0-0-0
Spring FMK 604 Experimental Pharmacology I Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Spring FMK 601 Mechanisms For Drug Action Graduate School of Health Scie... PHARMACY PHARMACOLOGY 3-0-3
Spring FMK 504 Drugs Affecting Renal System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Spring ILC202 Ilac Bilgisi II Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Spring ILC202 Pharmaceutical Information II Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall FMK 512 Experimental Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Fall FMK 501 General Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall FMK 504 Drugs Affecting Renal System Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-0-2
Fall ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Fall ILC201 Drug Information I Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Summer ILC201 Drug Information I Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Summer ILC201 Ilac Bilgisi I Vocational School of Mersin Pharmacy Services ( Distance E... 4-0-4
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ432 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 0-3-1
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ430 Pharmaceutical Care - Clinical Pharmacy ... Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring FMK 512 Experimental Pharmacology Graduate School of Health Scie... PHARMACY PHARMACOLOGY 2-4-4
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ503 Management of Community Pharmacy Faculty of Pharmacy Pharmacy 2-0-2
Fall TTP231 Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Fall EHP203 Study of Drugs I Vocational School of Mersin Pharmacy Services ( Distance E... 6-0-6
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ505 Community Pharmacy Practice Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall FMK 626 Pain and Analgesics Graduate School of Health Scie... PHARMACY PHARMACOLOGY 1-0-1
Fall TTP231 Vocational School of Mersin Medical Promotion and Marketin... 4-0-4
Fall EHP203 Study of Drugs I Vocational School of Mersin Pharmacy Services ( Distance E... 6-0-6
Summer ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Term C.Code Course Faculty/College/Institute Department/Program T-A-C
Spring ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Spring ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Spring ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ411 Pharmacology IV Faculty of Pharmacy Pharmacy 2-0-2
Fall ECZ435 Pharmacology Practise Faculty of Pharmacy Pharmacy 0-2-1
Fall ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Fall ECZ503 Management of Community Pharmacy Faculty of Pharmacy Pharmacy 2-0-2
Fall EHP203 Study of Drugs I Vocational School of Mersin Pharmacy Services ( Distance E... 6-0-6
Summer ECZ212 Pharmacology I Faculty of Pharmacy Pharmacy 3-0-3
Summer ECZ314 Pharmacology Iii Faculty of Pharmacy Pharmacy 2-0-2
Summer ECZ231 Physiology Faculty of Pharmacy Pharmacy 3-0-3
Summer ECZ325 Pharmacology II Faculty of Pharmacy Pharmacy 3-0-3
Summer ECZ420 Pharmacotherapy Faculty of Pharmacy Pharmacy 2-0-2